paradigm_id,type,patient_count,drug_count,drugs,description
C055,drug_combination,50,2,G-CSF; plerixafor,G-CSF + plerixafor
C054,drug_combination,50,2,filgrastim; plerixafor,filgrastim + plerixafor
C056,drug_combination,43,2,mesna; plerixafor,mesna + plerixafor
C057,drug_combination,40,2,pegfilgrastim; plerixafor,pegfilgrastim + plerixafor
C058,drug_combination,38,2,Cyclophosphamide; plerixafor,Cyclophosphamide + plerixafor
C059,drug_combination,38,2,Cyclophosphamid; plerixafor,Cyclophosphamid + plerixafor
C060,drug_combination,37,2,Vinblastin; vinblastine,Vinblastin + vinblastine
C061,drug_combination,34,2,plerixafor; vincristine,plerixafor + vincristine
C062,drug_combination,33,2,cisplatin; plerixafor,cisplatin + plerixafor
C063,drug_combination,32,2,irinotecan; vincristine,irinotecan + vincristine
C064,drug_combination,31,2,etoposide; plerixafor,etoposide + plerixafor
P001,complete_drug_set,31,2,carboplatin; vincristine,"2 drugs: carboplatin, vincristine"
C066,drug_combination,31,2,Cyclophosphamid; topotecan,Cyclophosphamid + topotecan
C065,drug_combination,31,2,Cyclophosphamide; topotecan,Cyclophosphamide + topotecan
C067,drug_combination,29,2,filgrastim; topotecan,filgrastim + topotecan
C068,drug_combination,27,2,pegfilgrastim; topotecan,pegfilgrastim + topotecan
C069,drug_combination,24,2,Cyclophosphamide; Neulasta,Cyclophosphamide + Neulasta
C070,drug_combination,24,2,Cyclophosphamid; Neulasta,Cyclophosphamid + Neulasta
C071,drug_combination,24,2,etoposide; topotecan,etoposide + topotecan
C072,drug_combination,21,2,Neulasta; vincristine,Neulasta + vincristine
C073,drug_combination,21,2,Vinblastin; bevacizumab,Vinblastin + bevacizumab
C074,drug_combination,21,2,bevacizumab; vinblastine,bevacizumab + vinblastine
C075,drug_combination,20,2,methotrexate; triamcinolone,methotrexate + triamcinolone
C076,drug_combination,19,2,Leucovorin; doxorubicin,Leucovorin + doxorubicin
C077,drug_combination,19,2,Neulasta; cisplatin,Neulasta + cisplatin
C078,drug_combination,19,2,bevacizumab; lomustine,bevacizumab + lomustine
C079,drug_combination,19,2,filgrastim; irinotecan,filgrastim + irinotecan
C080,drug_combination,18,2,irinotecan; pegfilgrastim,irinotecan + pegfilgrastim
C084,drug_combination,17,2,G-CSF; topotecan,G-CSF + topotecan
C081,drug_combination,17,2,Leucovorin; dexrazoxane,Leucovorin + dexrazoxane
C082,drug_combination,17,2,Cyclophosphamide; bevacizumab,Cyclophosphamide + bevacizumab
C083,drug_combination,17,2,Cyclophosphamid; bevacizumab,Cyclophosphamid + bevacizumab
C085,drug_combination,16,2,temozolomide; triamcinolone,temozolomide + triamcinolone
C086,drug_combination,16,2,G-CSF; Nivestym,G-CSF + Nivestym
C087,drug_combination,16,2,Nivestym; filgrastim,Nivestym + filgrastim
C088,drug_combination,16,2,bevacizumab; filgrastim,bevacizumab + filgrastim
C089,drug_combination,16,2,Ziextenzo; etoposide,Ziextenzo + etoposide
C090,drug_combination,15,2,Fulphila; pegfilgrastim,Fulphila + pegfilgrastim
C091,drug_combination,15,2,Fulphila; filgrastim,Fulphila + filgrastim
C098,drug_combination,14,2,Nivestym; pegfilgrastim,Nivestym + pegfilgrastim
C097,drug_combination,14,2,Nivestym; etoposide,Nivestym + etoposide
C092,drug_combination,14,2,gemcitabine; pegfilgrastim,gemcitabine + pegfilgrastim
C093,drug_combination,14,2,filgrastim; gemcitabine,filgrastim + gemcitabine
C094,drug_combination,14,2,Nivestym; mesna,Nivestym + mesna
C095,drug_combination,14,2,Cyclophosphamide; Nivestym,Cyclophosphamide + Nivestym
C099,drug_combination,14,2,G-CSF; ifosfamide,G-CSF + ifosfamide
C100,drug_combination,14,2,carboplatin; plerixafor,carboplatin + plerixafor
C101,drug_combination,14,2,Cyclophosphamide; thalidomide,Cyclophosphamide + thalidomide
C102,drug_combination,14,2,Cyclophosphamid; thalidomide,Cyclophosphamid + thalidomide
C096,drug_combination,14,2,Cyclophosphamid; Nivestym,Cyclophosphamid + Nivestym
C103,drug_combination,13,2,Nivestym; vincristine,Nivestym + vincristine
C105,drug_combination,13,2,GM-CSF; plerixafor,GM-CSF + plerixafor
C106,drug_combination,13,2,bevacizumab; topotecan,bevacizumab + topotecan
C107,drug_combination,13,2,etoposide; thalidomide,etoposide + thalidomide
C104,drug_combination,13,2,Investigational Chemotherapy (unspecified); filgrastim,Investigational Chemotherapy (unspecified) + filgrastim
P002,complete_drug_set,13,110,"***; 131-MIBG + Vorinostat; 1A46 Drug Substance; AMG386 and bevacizumab; AZD1775; AZD6244; Access to Experimental Drugs; Adjuvant Atezolizumab-Bevacizumab Therapy; Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; Anti-PD-1 Drugs; Antibody-Drug Conjugates; BRAF inhibitor dabrafenib and MEK inhibitor trametinib; Bevacizumab Avastin; Bevacizumab, Everolimus and LBH589; Bevacizumab-IRDye800CW; Bortezomib drug; CUDC-907; Cemiplimab REGN2810; Chemo with concomitant Capecitabine and KD018; Combination drug; Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; Combination, Rogaratinib + palbociclib + fulvestrant; DFMO; DIFLUOROMETHYLORNITHINE; DS-8273a + nivolumab; Dabrafenib and trametinib combination; Drug-based intervention; Drugs Approved for Childhood Cancers; Drugs Approved for Conditions Related to Cancer; Drugs Approved for Different Types of Cancer; ETBX-071 PSA-based Oncolytic Virus; Enzalutamide,, soft capsules, once daily; Everolimus Afinitor tablets; FOLFIRI-BEVACIZUMAB; Fenretinide; Fimepinostat; IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks; Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab; Indoximod; Investigational Chemotherapy (unspecified); Ipilimumab -/kg; LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide; LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide; MK-1775; Mocetinostat Induction Phase + Ipilimumab + Nivolumab; Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab; Nivolumab & Ipilimumab; Nivolumab -/kg; Nivolumab Protocol; Nivolumab and Hyaluronidase-nvhy; Nivolumab and Relatlimab-rmbw; Nivolumab induction; Nivolumab maintenance; Nivolumab with chemoradiation; Nivolumab-relatlimab FDC; ONC201; ONO-7475 once daily; Oncaspar; Oncolytic virus VRT106; PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001; PTC596; Palbociclib100mg; Palbociclib125mg; Pemetrexed and Gemcitabine plus Bevacizumab; Placebo - Concentrate; Recombinant oncolytic herpes simplex virus type Ⅰ R130; Relatlimab FDC + Nivolumab; SAHA(Suberoylanilide; SAHA-Suberoylanilide; SAHA/Vorinostat; Serplulimab combined with bevacizumab and first-line chemotherapy; Surufatinib; Surufatinib and Serplulimab; Surufatinib plus chemotherapy; TAK-580; Three-drug chemotherapy group; Trametinib placebo; Trastuzumab+Nivolumab+Gemcitabine+Cisplatin; Trifluridine/tipiracil + bevacizumab; albumin-bound paclitaxe combined with bevacizumab biosimilar; bevacizumab; capecitabine, oxaliplatin, irinotecan and bevacizumab; carboplatin paclitaxel bevacizumab; chlorambucil drug; concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME; concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX; dasatinib; epirubicin - cyclophosphamide / docetaxel + bevacizumab; everolimus; fenretinide lipid matrix; intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks; ipilimumab; loncastuximab tesirine; loncastuximab tesirine-lpyl; mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody; nivolumab; ntifier:ADVL0921; once daily for two consecutive days Picato; paclitaxel + everolimus RAD001; palbociclib; palbociclib isethionate; rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim; selinexor; standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001; tazemetostat; tazemetostat hydrobromide; trametinib; trametinib dimethyl sulfoxide; two-drug chemotherapy group; vorinostat","110 drugs: ***, 131-MIBG + Vorinostat, 1A46 Drug Substance, AMG386 and bevacizumab, AZD1775"
C111,drug_combination,12,2,bevacizumab; pegfilgrastim,bevacizumab + pegfilgrastim
C110,drug_combination,12,2,Nivestym; cisplatin,Nivestym + cisplatin
C109,drug_combination,12,2,Investigational Chemotherapy (unspecified); vincristine,Investigational Chemotherapy (unspecified) + vincristine
C108,drug_combination,12,2,doxorubicin; triamcinolone,doxorubicin + triamcinolone
C121,drug_combination,11,2,Etopophos; G-CSF,Etopophos + G-CSF
C125,drug_combination,11,2,carboplatin; etoposide phosphate,carboplatin + etoposide phosphate
C124,drug_combination,11,2,etoposide phosphate; filgrastim,etoposide phosphate + filgrastim
C127,drug_combination,11,2,Glutamine; etoposide phosphate,Glutamine + etoposide phosphate
C128,drug_combination,11,2,Etopophos; carboplatin,Etopophos + carboplatin
C129,drug_combination,11,2,Etopophos; Glutamine,Etopophos + Glutamine
C130,drug_combination,11,2,G-CSF; etoposide phosphate,G-CSF + etoposide phosphate
C122,drug_combination,11,2,Etopophos; etoposide phosphate,Etopophos + etoposide phosphate
C126,drug_combination,11,2,Etopophos; etoposide,Etopophos + etoposide
C112,drug_combination,11,2,dexrazoxane; triamcinolone,dexrazoxane + triamcinolone
C118,drug_combination,11,2,Neulasta; doxorubicin,Neulasta + doxorubicin
C123,drug_combination,11,2,etoposide; etoposide phosphate,etoposide + etoposide phosphate
C120,drug_combination,11,2,Etopophos; filgrastim,Etopophos + filgrastim
C119,drug_combination,11,2,Progesterone; filgrastim,Progesterone + filgrastim
C113,drug_combination,11,2,Leucovorin; triamcinolone,Leucovorin + triamcinolone
C117,drug_combination,11,2,GM-CSF; isotretinoin,GM-CSF + isotretinoin
C115,drug_combination,11,2,Rituxan; rituximab,Rituxan + rituximab
C114,drug_combination,11,2,Leucovorin; cytarabine,Leucovorin + cytarabine
C116,drug_combination,11,2,GM-CSF; tretinoin,GM-CSF + tretinoin
C139,drug_combination,10,2,etoposide; tretinoin,etoposide + tretinoin
C145,drug_combination,10,2,Glutamine; plerixafor,Glutamine + plerixafor
C144,drug_combination,10,2,Cyclophosphamid; irinotecan,Cyclophosphamid + irinotecan
C143,drug_combination,10,2,Cyclophosphamide; irinotecan,Cyclophosphamide + irinotecan
C142,drug_combination,10,2,cisplatin; topotecan,cisplatin + topotecan
C141,drug_combination,10,2,Progesterone; pegfilgrastim,Progesterone + pegfilgrastim
C140,drug_combination,10,2,Neulasta; dexrazoxane,Neulasta + dexrazoxane
C138,drug_combination,10,2,Investigational Chemotherapy (unspecified); pegfilgrastim,Investigational Chemotherapy (unspecified) + pegfilgrastim
C137,drug_combination,10,2,G-CSF; bevacizumab,G-CSF + bevacizumab
C136,drug_combination,10,2,trametinib; vincristine,trametinib + vincristine
C134,drug_combination,10,2,Cyclophosphamid; gemcitabine,Cyclophosphamid + gemcitabine
C133,drug_combination,10,2,gemcitabine; vincristine,gemcitabine + vincristine
C132,drug_combination,10,2,Fulphila; vincristine,Fulphila + vincristine
C131,drug_combination,10,2,Progesterone; bevacizumab,Progesterone + bevacizumab
C135,drug_combination,10,2,Cyclophosphamide; gemcitabine,Cyclophosphamide + gemcitabine
C146,drug_combination,9,2,Fulphila; etoposide,Fulphila + etoposide
C147,drug_combination,9,2,Cyclophosphamide; pemetrexed,Cyclophosphamide + pemetrexed
C148,drug_combination,9,2,filgrastim; pemetrexed,filgrastim + pemetrexed
C153,drug_combination,9,2,gemcitabine; mesna,gemcitabine + mesna
C158,drug_combination,9,2,ATRA; Cyclophosphamide,ATRA + Cyclophosphamide
C156,drug_combination,9,2,gemcitabine; pemetrexed,gemcitabine + pemetrexed
C155,drug_combination,9,2,mesna; pemetrexed,mesna + pemetrexed
C154,drug_combination,9,2,pegfilgrastim; pemetrexed,pegfilgrastim + pemetrexed
C149,drug_combination,9,2,cisplatin; gemcitabine,cisplatin + gemcitabine
C152,drug_combination,9,2,cisplatin; pemetrexed,cisplatin + pemetrexed
C151,drug_combination,9,2,pemetrexed; vincristine,pemetrexed + vincristine
C150,drug_combination,9,2,Cyclophosphamid; pemetrexed,Cyclophosphamid + pemetrexed
C159,drug_combination,9,2,Cyclophosphamid; Fulphila,Cyclophosphamid + Fulphila
C160,drug_combination,9,2,cytarabine; triamcinolone,cytarabine + triamcinolone
C161,drug_combination,9,2,Fulphila; cisplatin,Fulphila + cisplatin
C162,drug_combination,9,2,Cyclophosphamide; Fulphila,Cyclophosphamide + Fulphila
C163,drug_combination,9,2,Investigational Chemotherapy (unspecified); etoposide,Investigational Chemotherapy (unspecified) + etoposide
C164,drug_combination,9,2,Temozolomide capsule; triamcinolone,Temozolomide capsule + triamcinolone
C165,drug_combination,9,2,mercaptopurine; methotrexate,mercaptopurine + methotrexate
C166,drug_combination,9,2,Daunorubicin; cytarabine,Daunorubicin + cytarabine
C167,drug_combination,9,2,G-CSF; doxorubicin,G-CSF + doxorubicin
C168,drug_combination,9,2,GM-CSF; irinotecan,GM-CSF + irinotecan
C169,drug_combination,9,2,GM-CSF; topotecan,GM-CSF + topotecan
C170,drug_combination,9,2,GM-CSF; dinutuximab,GM-CSF + dinutuximab
C171,drug_combination,9,2,G-CSF; cytarabine,G-CSF + cytarabine
P003,complete_drug_set,9,8,Cyclophosphamid; Cyclophosphamide; amifostine; cisplatin; filgrastim; mesna; pegfilgrastim; vincristine,"8 drugs: Cyclophosphamid, Cyclophosphamide, amifostine, cisplatin, filgrastim"
C157,drug_combination,9,2,ATRA; Cyclophosphamid,ATRA + Cyclophosphamid
C172,drug_combination,8,2,Cyclophosphamide; tretinoin,Cyclophosphamide + tretinoin
C173,drug_combination,8,2,Cyclophosphamid; tretinoin,Cyclophosphamid + tretinoin
C174,drug_combination,8,2,Cyclophosphamide; isotretinoin,Cyclophosphamide + isotretinoin
C175,drug_combination,8,2,Cyclophosphamid; isotretinoin,Cyclophosphamid + isotretinoin
C177,drug_combination,8,2,irinotecan; triamcinolone,irinotecan + triamcinolone
C178,drug_combination,8,2,Nivestym; methotrexate,Nivestym + methotrexate
C179,drug_combination,8,2,Cyclophosphamide; tazemetostat,Cyclophosphamide + tazemetostat
C181,drug_combination,8,2,bevacizumab; cisplatin,bevacizumab + cisplatin
C182,drug_combination,8,2,ipilimumab; vincristine,ipilimumab + vincristine
C199,drug_combination,8,2,G-CSF; irinotecan,G-CSF + irinotecan
C198,drug_combination,8,2,Glutamine; melphalan,Glutamine + melphalan
C197,drug_combination,8,2,filgrastim; melphalan,filgrastim + melphalan
C196,drug_combination,8,2,G-CSF; melphalan,G-CSF + melphalan
C195,drug_combination,8,2,plerixafor; thiotepa,plerixafor + thiotepa
C194,drug_combination,8,2,Nivestym; plerixafor,Nivestym + plerixafor
C193,drug_combination,8,2,ifosfamide; plerixafor,ifosfamide + plerixafor
C192,drug_combination,8,2,G-CSF; dexrazoxane,G-CSF + dexrazoxane
C191,drug_combination,8,2,methotrexate; plerixafor,methotrexate + plerixafor
C190,drug_combination,8,2,Ziextenzo; carboplatin,Ziextenzo + carboplatin
C189,drug_combination,8,2,filgrastim; tretinoin,filgrastim + tretinoin
C188,drug_combination,8,2,Cyclophosphamid; tazemetostat,Cyclophosphamid + tazemetostat
C187,drug_combination,8,2,ipilimumab; pegfilgrastim,ipilimumab + pegfilgrastim
C186,drug_combination,8,2,nivolumab; pegfilgrastim,nivolumab + pegfilgrastim
C185,drug_combination,8,2,filgrastim; nivolumab,filgrastim + nivolumab
C184,drug_combination,8,2,filgrastim; ipilimumab,filgrastim + ipilimumab
C183,drug_combination,8,2,bevacizumab; tretinoin,bevacizumab + tretinoin
C180,drug_combination,8,2,nivolumab; vincristine,nivolumab + vincristine
C176,drug_combination,8,2,ATRA; filgrastim,ATRA + filgrastim
P004,complete_drug_set,8,2,Temozolomide capsule; temozolomide,"2 drugs: Temozolomide capsule, temozolomide"
C503,drug_combination,7,2,loncastuximab tesirine-lpyl; vincristine,loncastuximab tesirine-lpyl + vincristine
C413,drug_combination,7,2,DS-8273a + nivolumab; vincristine,DS-8273a + nivolumab + vincristine
C423,drug_combination,7,2,Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab; pegfilgrastim,Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab + pegfilgrastim
C422,drug_combination,7,2,Surufatinib plus chemotherapy; pegfilgrastim,Surufatinib plus chemotherapy + pegfilgrastim
C421,drug_combination,7,2,"Combination, Rogaratinib + palbociclib + fulvestrant; filgrastim","Combination, Rogaratinib + palbociclib + fulvestrant + filgrastim"
C420,drug_combination,7,2,Antibody-Drug Conjugates; filgrastim,Antibody-Drug Conjugates + filgrastim
C419,drug_combination,7,2,ETBX-071 PSA-based Oncolytic Virus; filgrastim,ETBX-071 PSA-based Oncolytic Virus + filgrastim
C418,drug_combination,7,2,Surufatinib; vincristine,Surufatinib + vincristine
C417,drug_combination,7,2,***; vincristine,*** + vincristine
C416,drug_combination,7,2,Trastuzumab+Nivolumab+Gemcitabine+Cisplatin; vincristine,Trastuzumab+Nivolumab+Gemcitabine+Cisplatin + vincristine
C415,drug_combination,7,2,"Bevacizumab, Everolimus and LBH589; pegfilgrastim","Bevacizumab, Everolimus and LBH589 + pegfilgrastim"
C414,drug_combination,7,2,palbociclib; pegfilgrastim,palbociclib + pegfilgrastim
C412,drug_combination,7,2,Nivolumab and Hyaluronidase-nvhy; vincristine,Nivolumab and Hyaluronidase-nvhy + vincristine
C425,drug_combination,7,2,loncastuximab tesirine; pegfilgrastim,loncastuximab tesirine + pegfilgrastim
C411,drug_combination,7,2,Bevacizumab Avastin; vincristine,Bevacizumab Avastin + vincristine
C410,drug_combination,7,2,Nivolumab with chemoradiation; filgrastim,Nivolumab with chemoradiation + filgrastim
C409,drug_combination,7,2,CUDC-907; pegfilgrastim,CUDC-907 + pegfilgrastim
C408,drug_combination,7,2,Ipilimumab -/kg; pegfilgrastim,Ipilimumab -/kg + pegfilgrastim
C407,drug_combination,7,2,Fenretinide; filgrastim,Fenretinide + filgrastim
C406,drug_combination,7,2,DFMO; filgrastim,DFMO + filgrastim
C405,drug_combination,7,2,SAHA-Suberoylanilide; pegfilgrastim,SAHA-Suberoylanilide + pegfilgrastim
C404,drug_combination,7,2,Placebo - Concentrate; filgrastim,Placebo - Concentrate + filgrastim
C403,drug_combination,7,2,Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab; filgrastim,Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab + filgrastim
C424,drug_combination,7,2,DFMO; pegfilgrastim,DFMO + pegfilgrastim
C426,drug_combination,7,2,Nivolumab Protocol; filgrastim,Nivolumab Protocol + filgrastim
C401,drug_combination,7,2,Drug-based intervention; vincristine,Drug-based intervention + vincristine
C439,drug_combination,7,2,Cemiplimab REGN2810; filgrastim,Cemiplimab REGN2810 + filgrastim
C449,drug_combination,7,2,Oncaspar; pegfilgrastim,Oncaspar + pegfilgrastim
C448,drug_combination,7,2,Oncolytic virus VRT106; pegfilgrastim,Oncolytic virus VRT106 + pegfilgrastim
C447,drug_combination,7,2,"pegfilgrastim; rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim","pegfilgrastim + rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim"
C446,drug_combination,7,2,carboplatin paclitaxel bevacizumab; pegfilgrastim,carboplatin paclitaxel bevacizumab + pegfilgrastim
C445,drug_combination,7,2,"Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab; vincristine","Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab + vincristine"
C444,drug_combination,7,2,131-MIBG + Vorinostat; filgrastim,131-MIBG + Vorinostat + filgrastim
C443,drug_combination,7,2,Nivolumab Protocol; pegfilgrastim,Nivolumab Protocol + pegfilgrastim
C442,drug_combination,7,2,"rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim; vincristine","rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim + vincristine"
C441,drug_combination,7,2,1A46 Drug Substance; pegfilgrastim,1A46 Drug Substance + pegfilgrastim
C440,drug_combination,7,2,Ipilimumab -/kg; vincristine,Ipilimumab -/kg + vincristine
C438,drug_combination,7,2,Combination drug; filgrastim,Combination drug + filgrastim
C427,drug_combination,7,2,Fenretinide; pegfilgrastim,Fenretinide + pegfilgrastim
C437,drug_combination,7,2,MK-1775; vincristine,MK-1775 + vincristine
C436,drug_combination,7,2,SAHA-Suberoylanilide; vincristine,SAHA-Suberoylanilide + vincristine
C435,drug_combination,7,2,Fimepinostat; vincristine,Fimepinostat + vincristine
C434,drug_combination,7,2,Three-drug chemotherapy group; filgrastim,Three-drug chemotherapy group + filgrastim
C433,drug_combination,7,2,Oncaspar; filgrastim,Oncaspar + filgrastim
C432,drug_combination,7,2,paclitaxel + everolimus RAD001; pegfilgrastim,paclitaxel + everolimus RAD001 + pegfilgrastim
C431,drug_combination,7,2,131-MIBG + Vorinostat; vincristine,131-MIBG + Vorinostat + vincristine
C430,drug_combination,7,2,albumin-bound paclitaxe combined with bevacizumab biosimilar; vincristine,albumin-bound paclitaxe combined with bevacizumab biosimilar + vincristine
C429,drug_combination,7,2,Nivolumab with chemoradiation; pegfilgrastim,Nivolumab with chemoradiation + pegfilgrastim
C428,drug_combination,7,2,Nivolumab and Hyaluronidase-nvhy; filgrastim,Nivolumab and Hyaluronidase-nvhy + filgrastim
C402,drug_combination,7,2,Serplulimab combined with bevacizumab and first-line chemotherapy; filgrastim,Serplulimab combined with bevacizumab and first-line chemotherapy + filgrastim
C400,drug_combination,7,2,concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX; vincristine,concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX + vincristine
C451,drug_combination,7,2,SAHA(Suberoylanilide; pegfilgrastim,SAHA(Suberoylanilide + pegfilgrastim
C375,drug_combination,7,2,"Enzalutamide,, soft capsules, once daily; pegfilgrastim","Enzalutamide,, soft capsules, once daily + pegfilgrastim"
C373,drug_combination,7,2,filgrastim; ntifier:ADVL0921,filgrastim + ntifier:ADVL0921
C372,drug_combination,7,2,Indoximod; pegfilgrastim,Indoximod + pegfilgrastim
C371,drug_combination,7,2,pegfilgrastim; trametinib dimethyl sulfoxide,pegfilgrastim + trametinib dimethyl sulfoxide
C370,drug_combination,7,2,Anti-PD-1 Drugs; filgrastim,Anti-PD-1 Drugs + filgrastim
C369,drug_combination,7,2,Access to Experimental Drugs; pegfilgrastim,Access to Experimental Drugs + pegfilgrastim
C368,drug_combination,7,2,"PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001; pegfilgrastim","PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001 + pegfilgrastim"
C367,drug_combination,7,2,chlorambucil drug; filgrastim,chlorambucil drug + filgrastim
C366,drug_combination,7,2,AZD6244; pegfilgrastim,AZD6244 + pegfilgrastim
C365,drug_combination,7,2,Cyclophosphamide; nivolumab,Cyclophosphamide + nivolumab
C364,drug_combination,7,2,ONO-7475 once daily; filgrastim,ONO-7475 once daily + filgrastim
C363,drug_combination,7,2,"Enzalutamide,, soft capsules, once daily; filgrastim","Enzalutamide,, soft capsules, once daily + filgrastim"
C362,drug_combination,7,2,Drugs Approved for Different Types of Cancer; pegfilgrastim,Drugs Approved for Different Types of Cancer + pegfilgrastim
C361,drug_combination,7,2,"Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; filgrastim","Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab + filgrastim"
C360,drug_combination,7,2,Chemo with concomitant Capecitabine and KD018; filgrastim,Chemo with concomitant Capecitabine and KD018 + filgrastim
C359,drug_combination,7,2,Recombinant oncolytic herpes simplex virus type Ⅰ R130; pegfilgrastim,Recombinant oncolytic herpes simplex virus type Ⅰ R130 + pegfilgrastim
C358,drug_combination,7,2,TAK-580; filgrastim,TAK-580 + filgrastim
C357,drug_combination,7,2,epirubicin - cyclophosphamide / docetaxel + bevacizumab; filgrastim,epirubicin - cyclophosphamide / docetaxel + bevacizumab + filgrastim
C356,drug_combination,7,2,Mocetinostat Induction Phase + Ipilimumab + Nivolumab; vincristine,Mocetinostat Induction Phase + Ipilimumab + Nivolumab + vincristine
C355,drug_combination,7,2,Trifluridine/tipiracil + bevacizumab; filgrastim,Trifluridine/tipiracil + bevacizumab + filgrastim
C354,drug_combination,7,2,chlorambucil drug; vincristine,chlorambucil drug + vincristine
C353,drug_combination,7,2,concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME; vincristine,concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME + vincristine
C374,drug_combination,7,2,epirubicin - cyclophosphamide / docetaxel + bevacizumab; pegfilgrastim,epirubicin - cyclophosphamide / docetaxel + bevacizumab + pegfilgrastim
C376,drug_combination,7,2,concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX; pegfilgrastim,concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX + pegfilgrastim
C399,drug_combination,7,2,FOLFIRI-BEVACIZUMAB; filgrastim,FOLFIRI-BEVACIZUMAB + filgrastim
C377,drug_combination,7,2,filgrastim; trametinib,filgrastim + trametinib
C398,drug_combination,7,2,albumin-bound paclitaxe combined with bevacizumab biosimilar; pegfilgrastim,albumin-bound paclitaxe combined with bevacizumab biosimilar + pegfilgrastim
C397,drug_combination,7,2,SAHA/Vorinostat; pegfilgrastim,SAHA/Vorinostat + pegfilgrastim
C396,drug_combination,7,2,pegfilgrastim; two-drug chemotherapy group,pegfilgrastim + two-drug chemotherapy group
C395,drug_combination,7,2,"Bevacizumab, Everolimus and LBH589; filgrastim","Bevacizumab, Everolimus and LBH589 + filgrastim"
C394,drug_combination,7,2,Indoximod; vincristine,Indoximod + vincristine
C393,drug_combination,7,2,Access to Experimental Drugs; vincristine,Access to Experimental Drugs + vincristine
C392,drug_combination,7,2,LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide; pegfilgrastim,LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide + pegfilgrastim
C391,drug_combination,7,2,Everolimus Afinitor tablets; filgrastim,Everolimus Afinitor tablets + filgrastim
C390,drug_combination,7,2,CUDC-907; filgrastim,CUDC-907 + filgrastim
C389,drug_combination,7,2,filgrastim; mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody,filgrastim + mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody
C388,drug_combination,7,2,Surufatinib; pegfilgrastim,Surufatinib + pegfilgrastim
C387,drug_combination,7,2,"capecitabine, oxaliplatin, irinotecan and bevacizumab; pegfilgrastim","capecitabine, oxaliplatin, irinotecan and bevacizumab + pegfilgrastim"
C386,drug_combination,7,2,fenretinide lipid matrix; vincristine,fenretinide lipid matrix + vincristine
C385,drug_combination,7,2,Trastuzumab+Nivolumab+Gemcitabine+Cisplatin; pegfilgrastim,Trastuzumab+Nivolumab+Gemcitabine+Cisplatin + pegfilgrastim
C384,drug_combination,7,2,Anti-PD-1 Drugs; pegfilgrastim,Anti-PD-1 Drugs + pegfilgrastim
C383,drug_combination,7,2,Bevacizumab Avastin; pegfilgrastim,Bevacizumab Avastin + pegfilgrastim
C382,drug_combination,7,2,Drugs Approved for Different Types of Cancer; vincristine,Drugs Approved for Different Types of Cancer + vincristine
C381,drug_combination,7,2,ntifier:ADVL0921; vincristine,ntifier:ADVL0921 + vincristine
C380,drug_combination,7,2,Everolimus Afinitor tablets; vincristine,Everolimus Afinitor tablets + vincristine
C379,drug_combination,7,2,Drug-based intervention; pegfilgrastim,Drug-based intervention + pegfilgrastim
C378,drug_combination,7,2,ONO-7475 once daily; pegfilgrastim,ONO-7475 once daily + pegfilgrastim
C450,drug_combination,7,2,Three-drug chemotherapy group; pegfilgrastim,Three-drug chemotherapy group + pegfilgrastim
C452,drug_combination,7,2,Surufatinib plus chemotherapy; vincristine,Surufatinib plus chemotherapy + vincristine
C504,drug_combination,7,2,ONC201; pegfilgrastim,ONC201 + pegfilgrastim
C528,drug_combination,7,2,filgrastim; isotretinoin,filgrastim + isotretinoin
C529,drug_combination,7,2,BRAF inhibitor dabrafenib and MEK inhibitor trametinib; vincristine,BRAF inhibitor dabrafenib and MEK inhibitor trametinib + vincristine
C530,drug_combination,7,2,"PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001; vincristine","PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001 + vincristine"
C531,drug_combination,7,2,etoposide; isotretinoin,etoposide + isotretinoin
C532,drug_combination,7,2,Drugs Approved for Different Types of Cancer; filgrastim,Drugs Approved for Different Types of Cancer + filgrastim
C533,drug_combination,7,2,epirubicin - cyclophosphamide / docetaxel + bevacizumab; vincristine,epirubicin - cyclophosphamide / docetaxel + bevacizumab + vincristine
C534,drug_combination,7,2,"Enzalutamide,, soft capsules, once daily; vincristine","Enzalutamide,, soft capsules, once daily + vincristine"
C535,drug_combination,7,2,fenretinide lipid matrix; filgrastim,fenretinide lipid matrix + filgrastim
C536,drug_combination,7,2,AZD6244; filgrastim,AZD6244 + filgrastim
C537,drug_combination,7,2,ONO-7475 once daily; vincristine,ONO-7475 once daily + vincristine
C538,drug_combination,7,2,"PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001; filgrastim","PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001 + filgrastim"
C539,drug_combination,7,2,Access to Experimental Drugs; filgrastim,Access to Experimental Drugs + filgrastim
C540,drug_combination,7,2,Neulasta; methotrexate,Neulasta + methotrexate
C541,drug_combination,7,2,Leucovorin; plerixafor,Leucovorin + plerixafor
C542,drug_combination,7,2,topotecan; vincristine,topotecan + vincristine
C543,drug_combination,7,2,Daunorubicin; dexrazoxane,Daunorubicin + dexrazoxane
C544,drug_combination,7,2,asparaginase; cytarabine,asparaginase + cytarabine
C545,drug_combination,7,2,dinutuximab; irinotecan,dinutuximab + irinotecan
C546,drug_combination,7,2,dinutuximab; temozolomide,dinutuximab + temozolomide
C548,drug_combination,7,2,irinotecan; mesna,irinotecan + mesna
C549,drug_combination,7,2,Cyclophosphamide; Progesterone,Cyclophosphamide + Progesterone
C550,drug_combination,7,2,Cyclophosphamid; Progesterone,Cyclophosphamid + Progesterone
C351,drug_combination,7,2,PTC596; vincristine,PTC596 + vincristine
C527,drug_combination,7,2,AZD6244; vincristine,AZD6244 + vincristine
C502,drug_combination,7,2,filgrastim; paclitaxel + everolimus RAD001,filgrastim + paclitaxel + everolimus RAD001
C526,drug_combination,7,2,Relatlimab FDC + Nivolumab; vincristine,Relatlimab FDC + Nivolumab + vincristine
C505,drug_combination,7,2,PTC596; filgrastim,PTC596 + filgrastim
C506,drug_combination,7,2,IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks; pegfilgrastim,IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks + pegfilgrastim
C507,drug_combination,7,2,Nivolumab -/kg; filgrastim,Nivolumab -/kg + filgrastim
C508,drug_combination,7,2,concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME; filgrastim,concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME + filgrastim
C509,drug_combination,7,2,BRAF inhibitor dabrafenib and MEK inhibitor trametinib; pegfilgrastim,BRAF inhibitor dabrafenib and MEK inhibitor trametinib + pegfilgrastim
C510,drug_combination,7,2,Mocetinostat Induction Phase + Ipilimumab + Nivolumab; filgrastim,Mocetinostat Induction Phase + Ipilimumab + Nivolumab + filgrastim
C511,drug_combination,7,2,Nivolumab maintenance; vincristine,Nivolumab maintenance + vincristine
C512,drug_combination,7,2,Palbociclib100mg; vincristine,Palbociclib100mg + vincristine
C513,drug_combination,7,2,Palbociclib125mg; vincristine,Palbociclib125mg + vincristine
C514,drug_combination,7,2,Trifluridine/tipiracil + bevacizumab; pegfilgrastim,Trifluridine/tipiracil + bevacizumab + pegfilgrastim
C515,drug_combination,7,2,TAK-580; pegfilgrastim,TAK-580 + pegfilgrastim
C516,drug_combination,7,2,Chemo with concomitant Capecitabine and KD018; pegfilgrastim,Chemo with concomitant Capecitabine and KD018 + pegfilgrastim
C517,drug_combination,7,2,"Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; pegfilgrastim","Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab + pegfilgrastim"
C518,drug_combination,7,2,palbociclib isethionate; pegfilgrastim,palbociclib isethionate + pegfilgrastim
C519,drug_combination,7,2,once daily for two consecutive days Picato; vincristine,once daily for two consecutive days Picato + vincristine
C520,drug_combination,7,2,filgrastim; trametinib dimethyl sulfoxide,filgrastim + trametinib dimethyl sulfoxide
C521,drug_combination,7,2,Nivolumab -/kg; pegfilgrastim,Nivolumab -/kg + pegfilgrastim
C522,drug_combination,7,2,Recombinant oncolytic herpes simplex virus type Ⅰ R130; vincristine,Recombinant oncolytic herpes simplex virus type Ⅰ R130 + vincristine
C523,drug_combination,7,2,chlorambucil drug; pegfilgrastim,chlorambucil drug + pegfilgrastim
C524,drug_combination,7,2,Mocetinostat Induction Phase + Ipilimumab + Nivolumab; pegfilgrastim,Mocetinostat Induction Phase + Ipilimumab + Nivolumab + pegfilgrastim
C525,drug_combination,7,2,pegfilgrastim; tazemetostat,pegfilgrastim + tazemetostat
C551,drug_combination,7,2,bevacizumab; thalidomide,bevacizumab + thalidomide
C501,drug_combination,7,2,Relatlimab FDC + Nivolumab; pegfilgrastim,Relatlimab FDC + Nivolumab + pegfilgrastim
C453,drug_combination,7,2,Dabrafenib and trametinib combination; vincristine,Dabrafenib and trametinib combination + vincristine
C476,drug_combination,7,2,Drugs Approved for Conditions Related to Cancer; filgrastim,Drugs Approved for Conditions Related to Cancer + filgrastim
C474,drug_combination,7,2,filgrastim; tazemetostat hydrobromide,filgrastim + tazemetostat hydrobromide
C473,drug_combination,7,2,SAHA(Suberoylanilide; vincristine,SAHA(Suberoylanilide + vincristine
C472,drug_combination,7,2,Oncolytic virus VRT106; vincristine,Oncolytic virus VRT106 + vincristine
C471,drug_combination,7,2,pegfilgrastim; selinexor,pegfilgrastim + selinexor
C470,drug_combination,7,2,Nivolumab induction; vincristine,Nivolumab induction + vincristine
C469,drug_combination,7,2,dasatinib; pegfilgrastim,dasatinib + pegfilgrastim
C468,drug_combination,7,2,carboplatin paclitaxel bevacizumab; vincristine,carboplatin paclitaxel bevacizumab + vincristine
C467,drug_combination,7,2,mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody; pegfilgrastim,mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody + pegfilgrastim
C466,drug_combination,7,2,Surufatinib and Serplulimab; filgrastim,Surufatinib and Serplulimab + filgrastim
C465,drug_combination,7,2,G-CSF; Investigational Chemotherapy (unspecified),G-CSF + Investigational Chemotherapy (unspecified)
C464,drug_combination,7,2,1A46 Drug Substance; vincristine,1A46 Drug Substance + vincristine
C463,drug_combination,7,2,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; filgrastim,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy + filgrastim
C462,drug_combination,7,2,pegfilgrastim; vorinostat,pegfilgrastim + vorinostat
C461,drug_combination,7,2,Nivolumab & Ipilimumab; vincristine,Nivolumab & Ipilimumab + vincristine
C460,drug_combination,7,2,Drugs Approved for Childhood Cancers; filgrastim,Drugs Approved for Childhood Cancers + filgrastim
C459,drug_combination,7,2,filgrastim; once daily for two consecutive days Picato,filgrastim + once daily for two consecutive days Picato
C458,drug_combination,7,2,Nivolumab and Relatlimab-rmbw; filgrastim,Nivolumab and Relatlimab-rmbw + filgrastim
C457,drug_combination,7,2,Surufatinib and Serplulimab; vincristine,Surufatinib and Serplulimab + vincristine
C456,drug_combination,7,2,Bortezomib drug; pegfilgrastim,Bortezomib drug + pegfilgrastim
C455,drug_combination,7,2,"Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab; filgrastim","Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab + filgrastim"
C454,drug_combination,7,2,Combination drug; pegfilgrastim,Combination drug + pegfilgrastim
C475,drug_combination,7,2,filgrastim; palbociclib,filgrastim + palbociclib
C477,drug_combination,7,2,AZD1775; filgrastim,AZD1775 + filgrastim
C500,drug_combination,7,2,Adjuvant Atezolizumab-Bevacizumab Therapy; filgrastim,Adjuvant Atezolizumab-Bevacizumab Therapy + filgrastim
C478,drug_combination,7,2,loncastuximab tesirine-lpyl; pegfilgrastim,loncastuximab tesirine-lpyl + pegfilgrastim
C499,drug_combination,7,2,Bevacizumab-IRDye800CW; filgrastim,Bevacizumab-IRDye800CW + filgrastim
C498,drug_combination,7,2,dasatinib; vincristine,dasatinib + vincristine
C497,drug_combination,7,2,mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody; vincristine,mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody + vincristine
C496,drug_combination,7,2,LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide; filgrastim,LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide + filgrastim
C495,drug_combination,7,2,Pemetrexed and Gemcitabine plus Bevacizumab; filgrastim,Pemetrexed and Gemcitabine plus Bevacizumab + filgrastim
C494,drug_combination,7,2,AZD1775; pegfilgrastim,AZD1775 + pegfilgrastim
C493,drug_combination,7,2,Trametinib placebo; filgrastim,Trametinib placebo + filgrastim
C492,drug_combination,7,2,ONC201; filgrastim,ONC201 + filgrastim
C491,drug_combination,7,2,once daily for two consecutive days Picato; pegfilgrastim,once daily for two consecutive days Picato + pegfilgrastim
C490,drug_combination,7,2,selinexor; vincristine,selinexor + vincristine
C489,drug_combination,7,2,"filgrastim; standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001","filgrastim + standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001"
C488,drug_combination,7,2,Bevacizumab-IRDye800CW; vincristine,Bevacizumab-IRDye800CW + vincristine
C487,drug_combination,7,2,everolimus; pegfilgrastim,everolimus + pegfilgrastim
C486,drug_combination,7,2,vincristine; vorinostat,vincristine + vorinostat
C485,drug_combination,7,2,AMG386 and bevacizumab; pegfilgrastim,AMG386 and bevacizumab + pegfilgrastim
C484,drug_combination,7,2,DIFLUOROMETHYLORNITHINE; vincristine,DIFLUOROMETHYLORNITHINE + vincristine
C483,drug_combination,7,2,Palbociclib100mg; pegfilgrastim,Palbociclib100mg + pegfilgrastim
C482,drug_combination,7,2,Nivolumab maintenance; pegfilgrastim,Nivolumab maintenance + pegfilgrastim
C481,drug_combination,7,2,Bortezomib drug; vincristine,Bortezomib drug + vincristine
C480,drug_combination,7,2,Nivolumab-relatlimab FDC; vincristine,Nivolumab-relatlimab FDC + vincristine
C479,drug_combination,7,2,intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks; vincristine,intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks + vincristine
C352,drug_combination,7,2,Nivolumab -/kg; vincristine,Nivolumab -/kg + vincristine
C547,drug_combination,7,2,carboplatin; temozolomide,carboplatin + temozolomide
C350,drug_combination,7,2,BRAF inhibitor dabrafenib and MEK inhibitor trametinib; filgrastim,BRAF inhibitor dabrafenib and MEK inhibitor trametinib + filgrastim
C246,drug_combination,7,2,Fimepinostat; filgrastim,Fimepinostat + filgrastim
C253,drug_combination,7,2,Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab; vincristine,Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab + vincristine
C252,drug_combination,7,2,Ipilimumab -/kg; filgrastim,Ipilimumab -/kg + filgrastim
C251,drug_combination,7,2,Serplulimab combined with bevacizumab and first-line chemotherapy; vincristine,Serplulimab combined with bevacizumab and first-line chemotherapy + vincristine
C250,drug_combination,7,2,MK-1775; filgrastim,MK-1775 + filgrastim
C249,drug_combination,7,2,SAHA-Suberoylanilide; filgrastim,SAHA-Suberoylanilide + filgrastim
C248,drug_combination,7,2,***; pegfilgrastim,*** + pegfilgrastim
C247,drug_combination,7,2,FOLFIRI-BEVACIZUMAB; vincristine,FOLFIRI-BEVACIZUMAB + vincristine
C245,drug_combination,7,2,DS-8273a + nivolumab; pegfilgrastim,DS-8273a + nivolumab + pegfilgrastim
C274,drug_combination,7,2,"Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab; pegfilgrastim","Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab + pegfilgrastim"
C244,drug_combination,7,2,"Bevacizumab, Everolimus and LBH589; vincristine","Bevacizumab, Everolimus and LBH589 + vincristine"
C243,drug_combination,7,2,Nivolumab and Hyaluronidase-nvhy; pegfilgrastim,Nivolumab and Hyaluronidase-nvhy + pegfilgrastim
C242,drug_combination,7,2,palbociclib; vincristine,palbociclib + vincristine
C241,drug_combination,7,2,albumin-bound paclitaxe combined with bevacizumab biosimilar; filgrastim,albumin-bound paclitaxe combined with bevacizumab biosimilar + filgrastim
C240,drug_combination,7,2,SAHA/Vorinostat; filgrastim,SAHA/Vorinostat + filgrastim
C239,drug_combination,7,2,"Combination, Rogaratinib + palbociclib + fulvestrant; pegfilgrastim","Combination, Rogaratinib + palbociclib + fulvestrant + pegfilgrastim"
C238,drug_combination,7,2,CUDC-907; vincristine,CUDC-907 + vincristine
C254,drug_combination,7,2,Cyclophosphamid; Investigational Chemotherapy (unspecified),Cyclophosphamid + Investigational Chemotherapy (unspecified)
C255,drug_combination,7,2,Placebo - Concentrate; vincristine,Placebo - Concentrate + vincristine
C256,drug_combination,7,2,DFMO; vincristine,DFMO + vincristine
C257,drug_combination,7,2,loncastuximab tesirine; vincristine,loncastuximab tesirine + vincristine
C272,drug_combination,7,2,Cyclophosphamid; nivolumab,Cyclophosphamid + nivolumab
C271,drug_combination,7,2,MK-1775; pegfilgrastim,MK-1775 + pegfilgrastim
C270,drug_combination,7,2,"Combination, Rogaratinib + palbociclib + fulvestrant; vincristine","Combination, Rogaratinib + palbociclib + fulvestrant + vincristine"
C269,drug_combination,7,2,Antibody-Drug Conjugates; vincristine,Antibody-Drug Conjugates + vincristine
C268,drug_combination,7,2,ETBX-071 PSA-based Oncolytic Virus; vincristine,ETBX-071 PSA-based Oncolytic Virus + vincristine
C267,drug_combination,7,2,Dabrafenib and trametinib combination; filgrastim,Dabrafenib and trametinib combination + filgrastim
C266,drug_combination,7,2,Surufatinib plus chemotherapy; filgrastim,Surufatinib plus chemotherapy + filgrastim
C265,drug_combination,7,2,Fimepinostat; pegfilgrastim,Fimepinostat + pegfilgrastim
C264,drug_combination,7,2,131-MIBG + Vorinostat; pegfilgrastim,131-MIBG + Vorinostat + pegfilgrastim
C263,drug_combination,7,2,paclitaxel + everolimus RAD001; vincristine,paclitaxel + everolimus RAD001 + vincristine
C262,drug_combination,7,2,"filgrastim; rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim","filgrastim + rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim"
C261,drug_combination,7,2,Nivolumab with chemoradiation; vincristine,Nivolumab with chemoradiation + vincristine
C260,drug_combination,7,2,Fenretinide; vincristine,Fenretinide + vincristine
C259,drug_combination,7,2,Cemiplimab REGN2810; pegfilgrastim,Cemiplimab REGN2810 + pegfilgrastim
C258,drug_combination,7,2,filgrastim; loncastuximab tesirine,filgrastim + loncastuximab tesirine
C237,drug_combination,7,2,Antibody-Drug Conjugates; pegfilgrastim,Antibody-Drug Conjugates + pegfilgrastim
C236,drug_combination,7,2,ETBX-071 PSA-based Oncolytic Virus; pegfilgrastim,ETBX-071 PSA-based Oncolytic Virus + pegfilgrastim
C235,drug_combination,7,2,LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide; filgrastim,LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide + filgrastim
C215,drug_combination,7,2,concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX; filgrastim,concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX + filgrastim
C213,drug_combination,7,2,ntifier:ADVL0921; pegfilgrastim,ntifier:ADVL0921 + pegfilgrastim
C212,drug_combination,7,2,Indoximod; filgrastim,Indoximod + filgrastim
C211,drug_combination,7,2,filgrastim; two-drug chemotherapy group,filgrastim + two-drug chemotherapy group
C210,drug_combination,7,2,Everolimus Afinitor tablets; pegfilgrastim,Everolimus Afinitor tablets + pegfilgrastim
C209,drug_combination,7,2,Cyclophosphamid; ipilimumab,Cyclophosphamid + ipilimumab
C208,drug_combination,7,2,GM-CSF; Nivestym,GM-CSF + Nivestym
C207,drug_combination,7,2,Leucovorin; Nivestym,Leucovorin + Nivestym
C206,drug_combination,7,2,cytarabine; mesna,cytarabine + mesna
C205,drug_combination,7,2,dactinomycin; triamcinolone,dactinomycin + triamcinolone
C204,drug_combination,7,2,temozolomide; topotecan,temozolomide + topotecan
C203,drug_combination,7,2,G-CSF; Temozolomide capsule,G-CSF + Temozolomide capsule
C202,drug_combination,7,2,leuprolide; leuprolide acetate,leuprolide + leuprolide acetate
C201,drug_combination,7,2,carboplatin; doxorubicin,carboplatin + doxorubicin
C200,drug_combination,7,2,carboplatin; dexrazoxane,carboplatin + dexrazoxane
C349,drug_combination,7,2,tazemetostat hydrobromide; vincristine,tazemetostat hydrobromide + vincristine
C214,drug_combination,7,2,Anti-PD-1 Drugs; vincristine,Anti-PD-1 Drugs + vincristine
C216,drug_combination,7,2,FOLFIRI-BEVACIZUMAB; pegfilgrastim,FOLFIRI-BEVACIZUMAB + pegfilgrastim
C234,drug_combination,7,2,Surufatinib; filgrastim,Surufatinib + filgrastim
C217,drug_combination,7,2,Drug-based intervention; filgrastim,Drug-based intervention + filgrastim
C233,drug_combination,7,2,Cyclophosphamid; dasatinib,Cyclophosphamid + dasatinib
C232,drug_combination,7,2,"capecitabine, oxaliplatin, irinotecan and bevacizumab; filgrastim","capecitabine, oxaliplatin, irinotecan and bevacizumab + filgrastim"
C231,drug_combination,7,2,filgrastim; palbociclib isethionate,filgrastim + palbociclib isethionate
C230,drug_combination,7,2,filgrastim; loncastuximab tesirine-lpyl,filgrastim + loncastuximab tesirine-lpyl
C229,drug_combination,7,2,***; filgrastim,*** + filgrastim
C228,drug_combination,7,2,Trastuzumab+Nivolumab+Gemcitabine+Cisplatin; filgrastim,Trastuzumab+Nivolumab+Gemcitabine+Cisplatin + filgrastim
C227,drug_combination,7,2,SAHA/Vorinostat; vincristine,SAHA/Vorinostat + vincristine
C226,drug_combination,7,2,DS-8273a + nivolumab; filgrastim,DS-8273a + nivolumab + filgrastim
C225,drug_combination,7,2,Bevacizumab Avastin; filgrastim,Bevacizumab Avastin + filgrastim
C223,drug_combination,7,2,Placebo - Concentrate; pegfilgrastim,Placebo - Concentrate + pegfilgrastim
C222,drug_combination,7,2,Serplulimab combined with bevacizumab and first-line chemotherapy; pegfilgrastim,Serplulimab combined with bevacizumab and first-line chemotherapy + pegfilgrastim
C221,drug_combination,7,2,LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide; vincristine,LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide + vincristine
C220,drug_combination,7,2,pegfilgrastim; trametinib,pegfilgrastim + trametinib
C219,drug_combination,7,2,"capecitabine, oxaliplatin, irinotecan and bevacizumab; vincristine","capecitabine, oxaliplatin, irinotecan and bevacizumab + vincristine"
C218,drug_combination,7,2,fenretinide lipid matrix; pegfilgrastim,fenretinide lipid matrix + pegfilgrastim
C273,drug_combination,7,2,Nivolumab Protocol; vincristine,Nivolumab Protocol + vincristine
C224,drug_combination,7,2,"standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001; vincristine","standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001 + vincristine"
C275,drug_combination,7,2,nivolumab; tretinoin,nivolumab + tretinoin
C331,drug_combination,7,2,ONC201; vincristine,ONC201 + vincristine
C329,drug_combination,7,2,Cyclophosphamide; dasatinib,Cyclophosphamide + dasatinib
C328,drug_combination,7,2,everolimus; filgrastim,everolimus + filgrastim
C327,drug_combination,7,2,trametinib dimethyl sulfoxide; vincristine,trametinib dimethyl sulfoxide + vincristine
C326,drug_combination,7,2,concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME; pegfilgrastim,concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME + pegfilgrastim
C325,drug_combination,7,2,AMG386 and bevacizumab; filgrastim,AMG386 and bevacizumab + filgrastim
C324,drug_combination,7,2,Palbociclib125mg; filgrastim,Palbociclib125mg + filgrastim
C323,drug_combination,7,2,PTC596; pegfilgrastim,PTC596 + pegfilgrastim
C322,drug_combination,7,2,Palbociclib100mg; filgrastim,Palbociclib100mg + filgrastim
C321,drug_combination,7,2,Nivolumab maintenance; filgrastim,Nivolumab maintenance + filgrastim
C320,drug_combination,7,2,AZD1775; vincristine,AZD1775 + vincristine
C319,drug_combination,7,2,Drugs Approved for Conditions Related to Cancer; vincristine,Drugs Approved for Conditions Related to Cancer + vincristine
C318,drug_combination,7,2,pegfilgrastim; tazemetostat hydrobromide,pegfilgrastim + tazemetostat hydrobromide
C317,drug_combination,7,2,Adjuvant Atezolizumab-Bevacizumab Therapy; pegfilgrastim,Adjuvant Atezolizumab-Bevacizumab Therapy + pegfilgrastim
C316,drug_combination,7,2,Bevacizumab-IRDye800CW; pegfilgrastim,Bevacizumab-IRDye800CW + pegfilgrastim
C315,drug_combination,7,2,everolimus; vincristine,everolimus + vincristine
C330,drug_combination,7,2,"pegfilgrastim; standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001","pegfilgrastim + standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001"
C332,drug_combination,7,2,Trametinib placebo; vincristine,Trametinib placebo + vincristine
C313,drug_combination,7,2,AMG386 and bevacizumab; vincristine,AMG386 and bevacizumab + vincristine
C333,drug_combination,7,2,IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks; vincristine,IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks + vincristine
C276,drug_combination,7,2,Oncaspar; vincristine,Oncaspar + vincristine
C348,drug_combination,7,2,IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks; filgrastim,IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks + filgrastim
C347,drug_combination,7,2,tazemetostat; vincristine,tazemetostat + vincristine
C346,drug_combination,7,2,Cyclophosphamide; Investigational Chemotherapy (unspecified),Cyclophosphamide + Investigational Chemotherapy (unspecified)
C345,drug_combination,7,2,Adjuvant Atezolizumab-Bevacizumab Therapy; vincristine,Adjuvant Atezolizumab-Bevacizumab Therapy + vincristine
C344,drug_combination,7,2,palbociclib isethionate; vincristine,palbociclib isethionate + vincristine
C343,drug_combination,7,2,"Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; vincristine","Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab + vincristine"
C342,drug_combination,7,2,Chemo with concomitant Capecitabine and KD018; vincristine,Chemo with concomitant Capecitabine and KD018 + vincristine
C341,drug_combination,7,2,TAK-580; vincristine,TAK-580 + vincristine
C340,drug_combination,7,2,Relatlimab FDC + Nivolumab; filgrastim,Relatlimab FDC + Nivolumab + filgrastim
C339,drug_combination,7,2,Palbociclib125mg; pegfilgrastim,Palbociclib125mg + pegfilgrastim
C338,drug_combination,7,2,Trifluridine/tipiracil + bevacizumab; vincristine,Trifluridine/tipiracil + bevacizumab + vincristine
C337,drug_combination,7,2,filgrastim; tazemetostat,filgrastim + tazemetostat
C335,drug_combination,7,2,LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide; vincristine,LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide + vincristine
C334,drug_combination,7,2,Pemetrexed and Gemcitabine plus Bevacizumab; vincristine,Pemetrexed and Gemcitabine plus Bevacizumab + vincristine
C314,drug_combination,7,2,DIFLUOROMETHYLORNITHINE; pegfilgrastim,DIFLUOROMETHYLORNITHINE + pegfilgrastim
C336,drug_combination,7,2,Recombinant oncolytic herpes simplex virus type Ⅰ R130; filgrastim,Recombinant oncolytic herpes simplex virus type Ⅰ R130 + filgrastim
C312,drug_combination,7,2,trametinib; tretinoin,trametinib + tretinoin
C285,drug_combination,7,2,Cemiplimab REGN2810; vincristine,Cemiplimab REGN2810 + vincristine
C292,drug_combination,7,2,Nivolumab induction; filgrastim,Nivolumab induction + filgrastim
C291,drug_combination,7,2,Surufatinib and Serplulimab; pegfilgrastim,Surufatinib and Serplulimab + pegfilgrastim
C290,drug_combination,7,2,filgrastim; selinexor,filgrastim + selinexor
C289,drug_combination,7,2,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; pegfilgrastim,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy + pegfilgrastim
C288,drug_combination,7,2,carboplatin paclitaxel bevacizumab; filgrastim,carboplatin paclitaxel bevacizumab + filgrastim
C287,drug_combination,7,2,1A46 Drug Substance; filgrastim,1A46 Drug Substance + filgrastim
C286,drug_combination,7,2,Drugs Approved for Childhood Cancers; pegfilgrastim,Drugs Approved for Childhood Cancers + pegfilgrastim
C283,drug_combination,7,2,Nivolumab and Relatlimab-rmbw; pegfilgrastim,Nivolumab and Relatlimab-rmbw + pegfilgrastim
C294,drug_combination,7,2,SAHA(Suberoylanilide; filgrastim,SAHA(Suberoylanilide + filgrastim
C282,drug_combination,7,2,Dabrafenib and trametinib combination; pegfilgrastim,Dabrafenib and trametinib combination + pegfilgrastim
C281,drug_combination,7,2,Nivolumab & Ipilimumab; filgrastim,Nivolumab & Ipilimumab + filgrastim
C280,drug_combination,7,2,filgrastim; vorinostat,filgrastim + vorinostat
C279,drug_combination,7,2,Three-drug chemotherapy group; vincristine,Three-drug chemotherapy group + vincristine
C311,drug_combination,7,2,LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide; pegfilgrastim,LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide + pegfilgrastim
C278,drug_combination,7,2,bevacizumab; mesna,bevacizumab + mesna
C277,drug_combination,7,2,two-drug chemotherapy group; vincristine,two-drug chemotherapy group + vincristine
C293,drug_combination,7,2,Oncolytic virus VRT106; filgrastim,Oncolytic virus VRT106 + filgrastim
C284,drug_combination,7,2,Combination drug; vincristine,Combination drug + vincristine
C295,drug_combination,7,2,Drugs Approved for Conditions Related to Cancer; pegfilgrastim,Drugs Approved for Conditions Related to Cancer + pegfilgrastim
C302,drug_combination,7,2,Cyclophosphamide; ipilimumab,Cyclophosphamide + ipilimumab
C308,drug_combination,7,2,dasatinib; filgrastim,dasatinib + filgrastim
C310,drug_combination,7,2,Nivolumab-relatlimab FDC; pegfilgrastim,Nivolumab-relatlimab FDC + pegfilgrastim
C296,drug_combination,7,2,Nivolumab & Ipilimumab; pegfilgrastim,Nivolumab & Ipilimumab + pegfilgrastim
C307,drug_combination,7,2,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; vincristine,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy + vincristine
C306,drug_combination,7,2,Trametinib placebo; pegfilgrastim,Trametinib placebo + pegfilgrastim
C304,drug_combination,7,2,Drugs Approved for Childhood Cancers; vincristine,Drugs Approved for Childhood Cancers + vincristine
C303,drug_combination,7,2,Nivolumab and Relatlimab-rmbw; vincristine,Nivolumab and Relatlimab-rmbw + vincristine
C305,drug_combination,7,2,intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks; pegfilgrastim,intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks + pegfilgrastim
C309,drug_combination,7,2,Pemetrexed and Gemcitabine plus Bevacizumab; pegfilgrastim,Pemetrexed and Gemcitabine plus Bevacizumab + pegfilgrastim
C301,drug_combination,7,2,Nivolumab induction; pegfilgrastim,Nivolumab induction + pegfilgrastim
C300,drug_combination,7,2,DIFLUOROMETHYLORNITHINE; filgrastim,DIFLUOROMETHYLORNITHINE + filgrastim
C299,drug_combination,7,2,filgrastim; intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks,filgrastim + intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks
C297,drug_combination,7,2,Nivolumab-relatlimab FDC; filgrastim,Nivolumab-relatlimab FDC + filgrastim
C298,drug_combination,7,2,Bortezomib drug; filgrastim,Bortezomib drug + filgrastim
C786,drug_combination,6,2,Nivolumab induction; tretinoin,Nivolumab induction + tretinoin
C777,drug_combination,6,2,Nivolumab & Ipilimumab; tretinoin,Nivolumab & Ipilimumab + tretinoin
C778,drug_combination,6,2,Cyclophosphamid; chlorambucil drug,Cyclophosphamid + chlorambucil drug
C779,drug_combination,6,2,Cyclophosphamid; Palbociclib100mg,Cyclophosphamid + Palbociclib100mg
C784,drug_combination,6,2,Cyclophosphamid; albumin-bound paclitaxe combined with bevacizumab biosimilar,Cyclophosphamid + albumin-bound paclitaxe combined with bevacizumab biosimilar
C780,drug_combination,6,2,1A46 Drug Substance; tretinoin,1A46 Drug Substance + tretinoin
C785,drug_combination,6,2,Cyclophosphamide; Everolimus Afinitor tablets,Cyclophosphamide + Everolimus Afinitor tablets
C782,drug_combination,6,2,carboplatin paclitaxel bevacizumab; tretinoin,carboplatin paclitaxel bevacizumab + tretinoin
C783,drug_combination,6,2,Cyclophosphamid; intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks,Cyclophosphamid + intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks
C776,drug_combination,6,2,Cyclophosphamid; Pemetrexed and Gemcitabine plus Bevacizumab,Cyclophosphamid + Pemetrexed and Gemcitabine plus Bevacizumab
C781,drug_combination,6,2,Cyclophosphamid; Dabrafenib and trametinib combination,Cyclophosphamid + Dabrafenib and trametinib combination
C771,drug_combination,6,2,Cyclophosphamid; Fimepinostat,Cyclophosphamid + Fimepinostat
C775,drug_combination,6,2,Cyclophosphamide; Fenretinide,Cyclophosphamide + Fenretinide
C774,drug_combination,6,2,Cyclophosphamid; Nivolumab & Ipilimumab,Cyclophosphamid + Nivolumab & Ipilimumab
C773,drug_combination,6,2,AMG386 and bevacizumab; Cyclophosphamid,AMG386 and bevacizumab + Cyclophosphamid
C772,drug_combination,6,2,AZD1775; Cyclophosphamide,AZD1775 + Cyclophosphamide
C770,drug_combination,6,2,Cyclophosphamid; selinexor,Cyclophosphamid + selinexor
C769,drug_combination,6,2,Cyclophosphamid; Mocetinostat Induction Phase + Ipilimumab + Nivolumab,Cyclophosphamid + Mocetinostat Induction Phase + Ipilimumab + Nivolumab
C768,drug_combination,6,2,"Cyclophosphamid; Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab","Cyclophosphamid + Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab"
C767,drug_combination,6,2,Cyclophosphamide; trametinib dimethyl sulfoxide,Cyclophosphamide + trametinib dimethyl sulfoxide
C788,drug_combination,6,2,SAHA(Suberoylanilide; tretinoin,SAHA(Suberoylanilide + tretinoin
C765,drug_combination,6,2,Dabrafenib and trametinib combination; tretinoin,Dabrafenib and trametinib combination + tretinoin
C766,drug_combination,6,2,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; Cyclophosphamide,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy + Cyclophosphamide
C787,drug_combination,6,2,Oncolytic virus VRT106; tretinoin,Oncolytic virus VRT106 + tretinoin
C804,drug_combination,6,2,Cyclophosphamide; Drugs Approved for Different Types of Cancer,Cyclophosphamide + Drugs Approved for Different Types of Cancer
C789,drug_combination,6,2,Cyclophosphamid; ONO-7475 once daily,Cyclophosphamid + ONO-7475 once daily
C802,drug_combination,6,2,"Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; Cyclophosphamid","Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab + Cyclophosphamid"
C812,drug_combination,6,2,Cyclophosphamide; palbociclib isethionate,Cyclophosphamide + palbociclib isethionate
C763,drug_combination,6,2,Cyclophosphamid; IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks,Cyclophosphamid + IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks
C811,drug_combination,6,2,Cyclophosphamide; loncastuximab tesirine-lpyl,Cyclophosphamide + loncastuximab tesirine-lpyl
C810,drug_combination,6,2,Cyclophosphamide; MK-1775,Cyclophosphamide + MK-1775
C809,drug_combination,6,2,Cyclophosphamide; Drug-based intervention,Cyclophosphamide + Drug-based intervention
C808,drug_combination,6,2,Cyclophosphamide; Surufatinib,Cyclophosphamide + Surufatinib
C807,drug_combination,6,2,dasatinib; tretinoin,dasatinib + tretinoin
C806,drug_combination,6,2,Cyclophosphamid; Nivolumab-relatlimab FDC,Cyclophosphamid + Nivolumab-relatlimab FDC
C805,drug_combination,6,2,mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody; tretinoin,mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody + tretinoin
C803,drug_combination,6,2,Cyclophosphamide; Nivolumab maintenance,Cyclophosphamide + Nivolumab maintenance
C801,drug_combination,6,2,selinexor; tretinoin,selinexor + tretinoin
C790,drug_combination,6,2,Cyclophosphamide; Three-drug chemotherapy group,Cyclophosphamide + Three-drug chemotherapy group
C800,drug_combination,6,2,Chemo with concomitant Capecitabine and KD018; Cyclophosphamid,Chemo with concomitant Capecitabine and KD018 + Cyclophosphamid
C799,drug_combination,6,2,Cyclophosphamid; Trifluridine/tipiracil + bevacizumab,Cyclophosphamid + Trifluridine/tipiracil + bevacizumab
C798,drug_combination,6,2,Cyclophosphamide; Trametinib placebo,Cyclophosphamide + Trametinib placebo
C797,drug_combination,6,2,BRAF inhibitor dabrafenib and MEK inhibitor trametinib; Cyclophosphamid,BRAF inhibitor dabrafenib and MEK inhibitor trametinib + Cyclophosphamid
C796,drug_combination,6,2,Adjuvant Atezolizumab-Bevacizumab Therapy; Cyclophosphamide,Adjuvant Atezolizumab-Bevacizumab Therapy + Cyclophosphamide
C795,drug_combination,6,2,Bevacizumab-IRDye800CW; Cyclophosphamide,Bevacizumab-IRDye800CW + Cyclophosphamide
C794,drug_combination,6,2,DIFLUOROMETHYLORNITHINE; tretinoin,DIFLUOROMETHYLORNITHINE + tretinoin
C793,drug_combination,6,2,Bortezomib drug; tretinoin,Bortezomib drug + tretinoin
C792,drug_combination,6,2,Nivolumab-relatlimab FDC; tretinoin,Nivolumab-relatlimab FDC + tretinoin
C791,drug_combination,6,2,Cyclophosphamide; two-drug chemotherapy group,Cyclophosphamide + two-drug chemotherapy group
C764,drug_combination,6,2,Surufatinib plus chemotherapy; tretinoin,Surufatinib plus chemotherapy + tretinoin
C726,drug_combination,6,2,Cyclophosphamide; Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab,Cyclophosphamide + Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab
C762,drug_combination,6,2,Cyclophosphamid; fenretinide lipid matrix,Cyclophosphamid + fenretinide lipid matrix
C723,drug_combination,6,2,Cyclophosphamide; PTC596,Cyclophosphamide + PTC596
C734,drug_combination,6,2,Trastuzumab+Nivolumab+Gemcitabine+Cisplatin; tretinoin,Trastuzumab+Nivolumab+Gemcitabine+Cisplatin + tretinoin
C733,drug_combination,6,2,"Cyclophosphamide; standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001","Cyclophosphamide + standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001"
C732,drug_combination,6,2,1A46 Drug Substance; Cyclophosphamid,1A46 Drug Substance + Cyclophosphamid
C731,drug_combination,6,2,Cyclophosphamid; Nivolumab and Hyaluronidase-nvhy,Cyclophosphamid + Nivolumab and Hyaluronidase-nvhy
C730,drug_combination,6,2,Cyclophosphamid; epirubicin - cyclophosphamide / docetaxel + bevacizumab,Cyclophosphamid + epirubicin - cyclophosphamide / docetaxel + bevacizumab
C729,drug_combination,6,2,DS-8273a + nivolumab; tretinoin,DS-8273a + nivolumab + tretinoin
C728,drug_combination,6,2,Nivolumab and Hyaluronidase-nvhy; tretinoin,Nivolumab and Hyaluronidase-nvhy + tretinoin
C727,drug_combination,6,2,Bevacizumab Avastin; tretinoin,Bevacizumab Avastin + tretinoin
C725,drug_combination,6,2,Cyclophosphamide; ONC201,Cyclophosphamide + ONC201
C724,drug_combination,6,2,Cyclophosphamid; ETBX-071 PSA-based Oncolytic Virus,Cyclophosphamid + ETBX-071 PSA-based Oncolytic Virus
C721,drug_combination,6,2,Cyclophosphamid; palbociclib isethionate,Cyclophosphamid + palbociclib isethionate
C736,drug_combination,6,2,***; tretinoin,*** + tretinoin
C720,drug_combination,6,2,Drug-based intervention; tretinoin,Drug-based intervention + tretinoin
C719,drug_combination,6,2,Cyclophosphamid; loncastuximab tesirine-lpyl,Cyclophosphamid + loncastuximab tesirine-lpyl
C718,drug_combination,6,2,Cyclophosphamid; MK-1775,Cyclophosphamid + MK-1775
C717,drug_combination,6,2,Antibody-Drug Conjugates; Cyclophosphamide,Antibody-Drug Conjugates + Cyclophosphamide
C716,drug_combination,6,2,Cyclophosphamid; Drug-based intervention,Cyclophosphamid + Drug-based intervention
C715,drug_combination,6,2,"Cyclophosphamide; PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001","Cyclophosphamide + PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001"
C714,drug_combination,6,2,Cyclophosphamide; palbociclib,Cyclophosphamide + palbociclib
C713,drug_combination,6,2,concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX; tretinoin,concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX + tretinoin
C712,drug_combination,6,2,Cyclophosphamid; ntifier:ADVL0921,Cyclophosphamid + ntifier:ADVL0921
C814,drug_combination,6,2,"Cyclophosphamid; Enzalutamide,, soft capsules, once daily","Cyclophosphamid + Enzalutamide,, soft capsules, once daily"
C735,drug_combination,6,2,Cyclophosphamide; Nivolumab with chemoradiation,Cyclophosphamide + Nivolumab with chemoradiation
C737,drug_combination,6,2,Cyclophosphamid; Nivolumab -/kg,Cyclophosphamid + Nivolumab -/kg
C761,drug_combination,6,2,Cyclophosphamide; Trastuzumab+Nivolumab+Gemcitabine+Cisplatin,Cyclophosphamide + Trastuzumab+Nivolumab+Gemcitabine+Cisplatin
C750,drug_combination,6,2,Fimepinostat; tretinoin,Fimepinostat + tretinoin
C760,drug_combination,6,2,Cyclophosphamide; LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide,Cyclophosphamide + LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide
C759,drug_combination,6,2,"Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab; tretinoin","Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab + tretinoin"
C758,drug_combination,6,2,"rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim; tretinoin","rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim + tretinoin"
C757,drug_combination,6,2,Cyclophosphamide; everolimus,Cyclophosphamide + everolimus
C756,drug_combination,6,2,Cyclophosphamide; Nivolumab and Relatlimab-rmbw,Cyclophosphamide + Nivolumab and Relatlimab-rmbw
C755,drug_combination,6,2,"Cyclophosphamide; capecitabine, oxaliplatin, irinotecan and bevacizumab","Cyclophosphamide + capecitabine, oxaliplatin, irinotecan and bevacizumab"
C754,drug_combination,6,2,Cyclophosphamide; SAHA/Vorinostat,Cyclophosphamide + SAHA/Vorinostat
C753,drug_combination,6,2,Ipilimumab -/kg; tretinoin,Ipilimumab -/kg + tretinoin
C752,drug_combination,6,2,MK-1775; tretinoin,MK-1775 + tretinoin
C751,drug_combination,6,2,SAHA-Suberoylanilide; tretinoin,SAHA-Suberoylanilide + tretinoin
C749,drug_combination,6,2,Bortezomib drug; Cyclophosphamid,Bortezomib drug + Cyclophosphamid
C738,drug_combination,6,2,Surufatinib; tretinoin,Surufatinib + tretinoin
C748,drug_combination,6,2,Cyclophosphamid; Drugs Approved for Childhood Cancers,Cyclophosphamid + Drugs Approved for Childhood Cancers
C747,drug_combination,6,2,Cyclophosphamide; paclitaxel + everolimus RAD001,Cyclophosphamide + paclitaxel + everolimus RAD001
C746,drug_combination,6,2,Cyclophosphamide; Oncaspar,Cyclophosphamide + Oncaspar
C745,drug_combination,6,2,Combination drug; Cyclophosphamid,Combination drug + Cyclophosphamid
C744,drug_combination,6,2,"Cyclophosphamid; rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim","Cyclophosphamid + rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim"
C743,drug_combination,6,2,albumin-bound paclitaxe combined with bevacizumab biosimilar; tretinoin,albumin-bound paclitaxe combined with bevacizumab biosimilar + tretinoin
C742,drug_combination,6,2,Cyclophosphamid; loncastuximab tesirine,Cyclophosphamid + loncastuximab tesirine
C741,drug_combination,6,2,131-MIBG + Vorinostat; Cyclophosphamide,131-MIBG + Vorinostat + Cyclophosphamide
C740,drug_combination,6,2,Cyclophosphamide; carboplatin paclitaxel bevacizumab,Cyclophosphamide + carboplatin paclitaxel bevacizumab
C739,drug_combination,6,2,Cemiplimab REGN2810; Cyclophosphamide,Cemiplimab REGN2810 + Cyclophosphamide
C813,drug_combination,6,2,Cyclophosphamid; Surufatinib and Serplulimab,Cyclophosphamid + Surufatinib and Serplulimab
C889,drug_combination,6,2,Etopophos; thiotepa,Etopophos + thiotepa
C815,drug_combination,6,2,Cyclophosphamide; ETBX-071 PSA-based Oncolytic Virus,Cyclophosphamide + ETBX-071 PSA-based Oncolytic Virus
C816,drug_combination,6,2,loncastuximab tesirine-lpyl; tretinoin,loncastuximab tesirine-lpyl + tretinoin
C891,drug_combination,6,2,cytarabine; pegaspargase,cytarabine + pegaspargase
C890,drug_combination,6,2,Daunorubicin; methotrexate,Daunorubicin + methotrexate
C710,drug_combination,6,2,tretinoin; two-drug chemotherapy group,tretinoin + two-drug chemotherapy group
C888,drug_combination,6,2,etoposide phosphate; thiotepa,etoposide phosphate + thiotepa
C887,drug_combination,6,2,Neulasta; dactinomycin,Neulasta + dactinomycin
C886,drug_combination,6,2,Cyclophosphamide; albumin-bound paclitaxe combined with bevacizumab biosimilar,Cyclophosphamide + albumin-bound paclitaxe combined with bevacizumab biosimilar
C885,drug_combination,6,2,Cyclophosphamide; intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks,Cyclophosphamide + intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks
C884,drug_combination,6,2,Cyclophosphamid; mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody,Cyclophosphamid + mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody
C883,drug_combination,6,2,LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide; tretinoin,LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide + tretinoin
C882,drug_combination,6,2,Cyclophosphamide; Dabrafenib and trametinib combination,Cyclophosphamide + Dabrafenib and trametinib combination
C881,drug_combination,6,2,Investigational Chemotherapy (unspecified); cisplatin,Investigational Chemotherapy (unspecified) + cisplatin
C880,drug_combination,6,2,Cyclophosphamide; Palbociclib100mg,Cyclophosphamide + Palbociclib100mg
C879,drug_combination,6,2,"capecitabine, oxaliplatin, irinotecan and bevacizumab; tretinoin","capecitabine, oxaliplatin, irinotecan and bevacizumab + tretinoin"
C878,drug_combination,6,2,Cyclophosphamide; chlorambucil drug,Cyclophosphamide + chlorambucil drug
C877,drug_combination,6,2,G-CSF; tretinoin,G-CSF + tretinoin
C876,drug_combination,6,2,Cyclophosphamide; Pemetrexed and Gemcitabine plus Bevacizumab,Cyclophosphamide + Pemetrexed and Gemcitabine plus Bevacizumab
C875,drug_combination,6,2,Cyclophosphamide; concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX,Cyclophosphamide + concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX
C874,drug_combination,6,2,***; Cyclophosphamide,*** + Cyclophosphamide
C873,drug_combination,6,2,Cyclophosphamide; Nivolumab & Ipilimumab,Cyclophosphamide + Nivolumab & Ipilimumab
C872,drug_combination,6,2,"Combination, Rogaratinib + palbociclib + fulvestrant; Cyclophosphamid","Combination, Rogaratinib + palbociclib + fulvestrant + Cyclophosphamid"
C871,drug_combination,6,2,Anti-PD-1 Drugs; tretinoin,Anti-PD-1 Drugs + tretinoin
C870,drug_combination,6,2,Antibody-Drug Conjugates; Cyclophosphamid,Antibody-Drug Conjugates + Cyclophosphamid
C869,drug_combination,6,2,Cyclophosphamide; Fimepinostat,Cyclophosphamide + Fimepinostat
C892,drug_combination,6,2,Tabloid; lomustine,Tabloid + lomustine
C893,drug_combination,6,2,Tabloid; vincristine,Tabloid + vincristine
C894,drug_combination,6,2,G-CSF; Zarxio,G-CSF + Zarxio
C907,drug_combination,6,2,carboplatin; melphalan,carboplatin + melphalan
C917,drug_combination,6,2,G-CSF; Neulasta,G-CSF + Neulasta
C916,drug_combination,6,2,carboplatin; irinotecan,carboplatin + irinotecan
C915,drug_combination,6,2,thalidomide; topotecan,thalidomide + topotecan
C914,drug_combination,6,2,mercaptopurine; vincristine,mercaptopurine + vincristine
C913,drug_combination,6,2,Neupogen; filgrastim,Neupogen + filgrastim
C912,drug_combination,6,2,Neupogen; pegfilgrastim,Neupogen + pegfilgrastim
C911,drug_combination,6,2,Lupron Depot; bevacizumab,Lupron Depot + bevacizumab
C910,drug_combination,6,2,bevacizumab; leuprolide,bevacizumab + leuprolide
C909,drug_combination,6,2,Mekinist; triamcinolone,Mekinist + triamcinolone
C908,drug_combination,6,2,ATRA; etoposide,ATRA + etoposide
C906,drug_combination,6,2,etoposide; melphalan,etoposide + melphalan
C895,drug_combination,6,2,Zarxio; filgrastim,Zarxio + filgrastim
C905,drug_combination,6,2,vinblastine; vincristine,vinblastine + vincristine
C904,drug_combination,6,2,Vinblastin; vincristine,Vinblastin + vincristine
C903,drug_combination,6,2,Emend; bevacizumab,Emend + bevacizumab
C902,drug_combination,6,2,Progesterone; etoposide,Progesterone + etoposide
C901,drug_combination,6,2,Progesterone; mesna,Progesterone + mesna
C900,drug_combination,6,2,filgrastim; propranolol,filgrastim + propranolol
C899,drug_combination,6,2,G-CSF; propranolol,G-CSF + propranolol
C898,drug_combination,6,2,Cyclophosphamid; Zarxio,Cyclophosphamid + Zarxio
C897,drug_combination,6,2,Cyclophosphamide; Zarxio,Cyclophosphamide + Zarxio
C896,drug_combination,6,2,Zarxio; pegfilgrastim,Zarxio + pegfilgrastim
C868,drug_combination,6,2,Cyclophosphamide; selinexor,Cyclophosphamide + selinexor
C867,drug_combination,6,2,Anti-PD-1 Drugs; Cyclophosphamide,Anti-PD-1 Drugs + Cyclophosphamide
C866,drug_combination,6,2,Bevacizumab Avastin; Cyclophosphamide,Bevacizumab Avastin + Cyclophosphamide
C828,drug_combination,6,2,Cyclophosphamid; DFMO,Cyclophosphamid + DFMO
C838,drug_combination,6,2,Recombinant oncolytic herpes simplex virus type Ⅰ R130; tretinoin,Recombinant oncolytic herpes simplex virus type Ⅰ R130 + tretinoin
C837,drug_combination,6,2,Cyclophosphamid; carboplatin paclitaxel bevacizumab,Cyclophosphamid + carboplatin paclitaxel bevacizumab
C836,drug_combination,6,2,"Cyclophosphamide; rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim","Cyclophosphamide + rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim"
C835,drug_combination,6,2,Cyclophosphamide; LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide,Cyclophosphamide + LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide
C834,drug_combination,6,2,Cyclophosphamid; Recombinant oncolytic herpes simplex virus type Ⅰ R130,Cyclophosphamid + Recombinant oncolytic herpes simplex virus type Ⅰ R130
C833,drug_combination,6,2,Cyclophosphamid; SAHA-Suberoylanilide,Cyclophosphamid + SAHA-Suberoylanilide
C832,drug_combination,6,2,Cyclophosphamide; loncastuximab tesirine,Cyclophosphamide + loncastuximab tesirine
C831,drug_combination,6,2,once daily for two consecutive days Picato; tretinoin,once daily for two consecutive days Picato + tretinoin
C830,drug_combination,6,2,Cyclophosphamid; Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab,Cyclophosphamid + Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab
C829,drug_combination,6,2,Cyclophosphamide; Nivolumab -/kg,Cyclophosphamide + Nivolumab -/kg
C827,drug_combination,6,2,Cyclophosphamid; concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME,Cyclophosphamid + concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME
C840,drug_combination,6,2,Cyclophosphamid; Nivolumab Protocol,Cyclophosphamid + Nivolumab Protocol
C826,drug_combination,6,2,Cyclophosphamide; Nivolumab induction,Cyclophosphamide + Nivolumab induction
C825,drug_combination,6,2,Palbociclib125mg; tretinoin,Palbociclib125mg + tretinoin
C824,drug_combination,6,2,Palbociclib100mg; tretinoin,Palbociclib100mg + tretinoin
C823,drug_combination,6,2,Nivolumab maintenance; tretinoin,Nivolumab maintenance + tretinoin
C822,drug_combination,6,2,Cyclophosphamid; PTC596,Cyclophosphamid + PTC596
C821,drug_combination,6,2,Cyclophosphamide; Nivolumab and Hyaluronidase-nvhy,Cyclophosphamide + Nivolumab and Hyaluronidase-nvhy
C820,drug_combination,6,2,Cyclophosphamide; epirubicin - cyclophosphamide / docetaxel + bevacizumab,Cyclophosphamide + epirubicin - cyclophosphamide / docetaxel + bevacizumab
C819,drug_combination,6,2,Cyclophosphamid; Palbociclib125mg,Cyclophosphamid + Palbociclib125mg
C818,drug_combination,6,2,"Cyclophosphamid; PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001","Cyclophosphamid + PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001"
C817,drug_combination,6,2,Cyclophosphamid; palbociclib,Cyclophosphamid + palbociclib
C839,drug_combination,6,2,CUDC-907; Cyclophosphamid,CUDC-907 + Cyclophosphamid
C841,drug_combination,6,2,Relatlimab FDC + Nivolumab; tretinoin,Relatlimab FDC + Nivolumab + tretinoin
C865,drug_combination,6,2,Cyclophosphamid; DS-8273a + nivolumab,Cyclophosphamid + DS-8273a + nivolumab
C854,drug_combination,6,2,Cyclophosphamide; fenretinide lipid matrix,Cyclophosphamide + fenretinide lipid matrix
C864,drug_combination,6,2,Cyclophosphamide; Mocetinostat Induction Phase + Ipilimumab + Nivolumab,Cyclophosphamide + Mocetinostat Induction Phase + Ipilimumab + Nivolumab
C863,drug_combination,6,2,Cyclophosphamid; Indoximod,Cyclophosphamid + Indoximod
C862,drug_combination,6,2,Cyclophosphamid; Trastuzumab+Nivolumab+Gemcitabine+Cisplatin,Cyclophosphamid + Trastuzumab+Nivolumab+Gemcitabine+Cisplatin
C861,drug_combination,6,2,Cyclophosphamide; Surufatinib plus chemotherapy,Cyclophosphamide + Surufatinib plus chemotherapy
C860,drug_combination,6,2,Cyclophosphamid; trametinib,Cyclophosphamid + trametinib
C859,drug_combination,6,2,ONO-7475 once daily; tretinoin,ONO-7475 once daily + tretinoin
C858,drug_combination,6,2,"Cyclophosphamide; Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab","Cyclophosphamide + Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab"
C857,drug_combination,6,2,Cyclophosphamide; vorinostat,Cyclophosphamide + vorinostat
C856,drug_combination,6,2,"Enzalutamide,, soft capsules, once daily; tretinoin","Enzalutamide,, soft capsules, once daily + tretinoin"
C855,drug_combination,6,2,Cyclophosphamide; IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks,Cyclophosphamide + IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks
C853,drug_combination,6,2,"Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; tretinoin","Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab + tretinoin"
C842,drug_combination,6,2,AZD6244; Cyclophosphamide,AZD6244 + Cyclophosphamide
C852,drug_combination,6,2,Cyclophosphamid; Nivolumab and Relatlimab-rmbw,Cyclophosphamid + Nivolumab and Relatlimab-rmbw
C851,drug_combination,6,2,epirubicin - cyclophosphamide / docetaxel + bevacizumab; tretinoin,epirubicin - cyclophosphamide / docetaxel + bevacizumab + tretinoin
C850,drug_combination,6,2,Trifluridine/tipiracil + bevacizumab; tretinoin,Trifluridine/tipiracil + bevacizumab + tretinoin
C849,drug_combination,6,2,"Cyclophosphamid; capecitabine, oxaliplatin, irinotecan and bevacizumab","Cyclophosphamid + capecitabine, oxaliplatin, irinotecan and bevacizumab"
C848,drug_combination,6,2,Cyclophosphamid; SAHA/Vorinostat,Cyclophosphamid + SAHA/Vorinostat
C847,drug_combination,6,2,"PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001; tretinoin","PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001 + tretinoin"
C846,drug_combination,6,2,BRAF inhibitor dabrafenib and MEK inhibitor trametinib; tretinoin,BRAF inhibitor dabrafenib and MEK inhibitor trametinib + tretinoin
C845,drug_combination,6,2,Access to Experimental Drugs; Cyclophosphamide,Access to Experimental Drugs + Cyclophosphamide
C844,drug_combination,6,2,AZD6244; tretinoin,AZD6244 + tretinoin
C843,drug_combination,6,2,Cyclophosphamid; Ipilimumab -/kg,Cyclophosphamid + Ipilimumab -/kg
C711,drug_combination,6,2,Cyclophosphamide; tazemetostat hydrobromide,Cyclophosphamide + tazemetostat hydrobromide
C722,drug_combination,6,2,"Combination, Rogaratinib + palbociclib + fulvestrant; Cyclophosphamide","Combination, Rogaratinib + palbociclib + fulvestrant + Cyclophosphamide"
C709,drug_combination,6,2,Indoximod; tretinoin,Indoximod + tretinoin
C600,drug_combination,6,2,Antibody-Drug Conjugates; tretinoin,Antibody-Drug Conjugates + tretinoin
C607,drug_combination,6,2,AZD1775; Cyclophosphamid,AZD1775 + Cyclophosphamid
C606,drug_combination,6,2,Nivolumab Protocol; tretinoin,Nivolumab Protocol + tretinoin
C605,drug_combination,6,2,Cyclophosphamide; DFMO,Cyclophosphamide + DFMO
C604,drug_combination,6,2,Cyclophosphamide; SAHA(Suberoylanilide,Cyclophosphamide + SAHA(Suberoylanilide
C603,drug_combination,6,2,Cyclophosphamide; concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME,Cyclophosphamide + concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME
C602,drug_combination,6,2,"Combination, Rogaratinib + palbociclib + fulvestrant; tretinoin","Combination, Rogaratinib + palbociclib + fulvestrant + tretinoin"
C601,drug_combination,6,2,1A46 Drug Substance; Cyclophosphamide,1A46 Drug Substance + Cyclophosphamide
C599,drug_combination,6,2,ETBX-071 PSA-based Oncolytic Virus; tretinoin,ETBX-071 PSA-based Oncolytic Virus + tretinoin
C609,drug_combination,6,2,Oncaspar; tretinoin,Oncaspar + tretinoin
C598,drug_combination,6,2,Cyclophosphamide; Palbociclib125mg,Cyclophosphamide + Palbociclib125mg
C597,drug_combination,6,2,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; Cyclophosphamid,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy + Cyclophosphamid
C596,drug_combination,6,2,Cyclophosphamid; Surufatinib,Cyclophosphamid + Surufatinib
C595,drug_combination,6,2,paclitaxel + everolimus RAD001; tretinoin,paclitaxel + everolimus RAD001 + tretinoin
C594,drug_combination,6,2,Investigational Chemotherapy (unspecified); tretinoin,Investigational Chemotherapy (unspecified) + tretinoin
C593,drug_combination,6,2,"Cyclophosphamide; Enzalutamide,, soft capsules, once daily","Cyclophosphamide + Enzalutamide,, soft capsules, once daily"
C592,drug_combination,6,2,Cyclophosphamide; Surufatinib and Serplulimab,Cyclophosphamide + Surufatinib and Serplulimab
C608,drug_combination,6,2,Cyclophosphamid; Nivolumab induction,Cyclophosphamid + Nivolumab induction
C610,drug_combination,6,2,Three-drug chemotherapy group; tretinoin,Three-drug chemotherapy group + tretinoin
C590,drug_combination,6,2,Fenretinide; tretinoin,Fenretinide + tretinoin
C620,drug_combination,6,2,Cyclophosphamide; Ipilimumab -/kg,Cyclophosphamide + Ipilimumab -/kg
C627,drug_combination,6,2,Cyclophosphamide; ntifier:ADVL0921,Cyclophosphamide + ntifier:ADVL0921
C626,drug_combination,6,2,ipilimumab; tretinoin,ipilimumab + tretinoin
C625,drug_combination,6,2,Adjuvant Atezolizumab-Bevacizumab Therapy; Cyclophosphamid,Adjuvant Atezolizumab-Bevacizumab Therapy + Cyclophosphamid
C624,drug_combination,6,2,Bevacizumab-IRDye800CW; Cyclophosphamid,Bevacizumab-IRDye800CW + Cyclophosphamid
C623,drug_combination,6,2,Cyclophosphamid; once daily for two consecutive days Picato,Cyclophosphamid + once daily for two consecutive days Picato
C622,drug_combination,6,2,Cyclophosphamid; Drugs Approved for Conditions Related to Cancer,Cyclophosphamid + Drugs Approved for Conditions Related to Cancer
C621,drug_combination,6,2,Cyclophosphamid; Relatlimab FDC + Nivolumab,Cyclophosphamid + Relatlimab FDC + Nivolumab
C619,drug_combination,6,2,131-MIBG + Vorinostat; tretinoin,131-MIBG + Vorinostat + tretinoin
C611,drug_combination,6,2,Cyclophosphamide; SAHA-Suberoylanilide,Cyclophosphamide + SAHA-Suberoylanilide
C618,drug_combination,6,2,Cyclophosphamid; LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide,Cyclophosphamid + LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide
C617,drug_combination,6,2,Cyclophosphamide; Nivolumab Protocol,Cyclophosphamide + Nivolumab Protocol
C616,drug_combination,6,2,Cemiplimab REGN2810; tretinoin,Cemiplimab REGN2810 + tretinoin
C615,drug_combination,6,2,Combination drug; tretinoin,Combination drug + tretinoin
C614,drug_combination,6,2,Bortezomib drug; Cyclophosphamide,Bortezomib drug + Cyclophosphamide
C613,drug_combination,6,2,Combination drug; Cyclophosphamide,Combination drug + Cyclophosphamide
C612,drug_combination,6,2,Cyclophosphamide; Recombinant oncolytic herpes simplex virus type Ⅰ R130,Cyclophosphamide + Recombinant oncolytic herpes simplex virus type Ⅰ R130
C591,drug_combination,6,2,Nivolumab with chemoradiation; tretinoin,Nivolumab with chemoradiation + tretinoin
C589,drug_combination,6,2,Cyclophosphamid; DIFLUOROMETHYLORNITHINE,Cyclophosphamid + DIFLUOROMETHYLORNITHINE
C629,drug_combination,6,2,Cyclophosphamide; trametinib,Cyclophosphamide + trametinib
C559,drug_combination,6,2,Fulphila; carboplatin,Fulphila + carboplatin
C566,drug_combination,6,2,"standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001; tretinoin","standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001 + tretinoin"
C565,drug_combination,6,2,Fulphila; mesna,Fulphila + mesna
C564,drug_combination,6,2,ATRA; pegfilgrastim,ATRA + pegfilgrastim
C563,drug_combination,6,2,ATRA; mesna,ATRA + mesna
C562,drug_combination,6,2,Investigational Chemotherapy (unspecified); Mekinist,Investigational Chemotherapy (unspecified) + Mekinist
C561,drug_combination,6,2,Progesterone; Temozolomide capsule,Progesterone + Temozolomide capsule
C560,drug_combination,6,2,Progesterone; temozolomide,Progesterone + temozolomide
C558,drug_combination,6,2,Valproic Acid; carboplatin,Valproic Acid + carboplatin
C568,drug_combination,6,2,SAHA/Vorinostat; tretinoin,SAHA/Vorinostat + tretinoin
C557,drug_combination,6,2,Cyclophosphamide; Rituxan,Cyclophosphamide + Rituxan
C556,drug_combination,6,2,Cyclophosphamid; rituximab,Cyclophosphamid + rituximab
C555,drug_combination,6,2,Cyclophosphamide; rituximab,Cyclophosphamide + rituximab
C554,drug_combination,6,2,Cyclophosphamid; Rituxan,Cyclophosphamid + Rituxan
C553,drug_combination,6,2,Progesterone; nivolumab,Progesterone + nivolumab
C552,drug_combination,6,2,Progesterone; triamcinolone,Progesterone + triamcinolone
C708,drug_combination,6,2,Cyclophosphamid; Drugs Approved for Different Types of Cancer,Cyclophosphamid + Drugs Approved for Different Types of Cancer
C567,drug_combination,6,2,Cyclophosphamid; Placebo - Concentrate,Cyclophosphamid + Placebo - Concentrate
C569,drug_combination,6,2,Cyclophosphamide; ONO-7475 once daily,Cyclophosphamide + ONO-7475 once daily
C588,drug_combination,6,2,loncastuximab tesirine; tretinoin,loncastuximab tesirine + tretinoin
C580,drug_combination,6,2,FOLFIRI-BEVACIZUMAB; tretinoin,FOLFIRI-BEVACIZUMAB + tretinoin
C587,drug_combination,6,2,DFMO; tretinoin,DFMO + tretinoin
C586,drug_combination,6,2,Placebo - Concentrate; tretinoin,Placebo - Concentrate + tretinoin
C585,drug_combination,6,2,Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab; tretinoin,Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab + tretinoin
C584,drug_combination,6,2,Cyclophosphamide; Nivolumab-relatlimab FDC,Cyclophosphamide + Nivolumab-relatlimab FDC
C583,drug_combination,6,2,Serplulimab combined with bevacizumab and first-line chemotherapy; tretinoin,Serplulimab combined with bevacizumab and first-line chemotherapy + tretinoin
C582,drug_combination,6,2,Cyclophosphamid; TAK-580,Cyclophosphamid + TAK-580
C581,drug_combination,6,2,Cyclophosphamide; Serplulimab combined with bevacizumab and first-line chemotherapy,Cyclophosphamide + Serplulimab combined with bevacizumab and first-line chemotherapy
C579,drug_combination,6,2,"Bevacizumab, Everolimus and LBH589; tretinoin","Bevacizumab, Everolimus and LBH589 + tretinoin"
C570,drug_combination,6,2,Cemiplimab REGN2810; Cyclophosphamid,Cemiplimab REGN2810 + Cyclophosphamid
C578,drug_combination,6,2,palbociclib; tretinoin,palbociclib + tretinoin
C577,drug_combination,6,2,G-CSF; isotretinoin,G-CSF + isotretinoin
C576,drug_combination,6,2,"Bevacizumab, Everolimus and LBH589; Cyclophosphamide","Bevacizumab, Everolimus and LBH589 + Cyclophosphamide"
C574,drug_combination,6,2,Cyclophosphamid; Three-drug chemotherapy group,Cyclophosphamid + Three-drug chemotherapy group
C573,drug_combination,6,2,Cyclophosphamid; Oncolytic virus VRT106,Cyclophosphamid + Oncolytic virus VRT106
C572,drug_combination,6,2,131-MIBG + Vorinostat; Cyclophosphamid,131-MIBG + Vorinostat + Cyclophosphamid
C571,drug_combination,6,2,Cyclophosphamid; Everolimus Afinitor tablets,Cyclophosphamid + Everolimus Afinitor tablets
C628,drug_combination,6,2,Cyclophosphamid; FOLFIRI-BEVACIZUMAB,Cyclophosphamid + FOLFIRI-BEVACIZUMAB
C575,drug_combination,6,2,CUDC-907; tretinoin,CUDC-907 + tretinoin
C630,drug_combination,6,2,Cyclophosphamide; Indoximod,Cyclophosphamide + Indoximod
C680,drug_combination,6,2,PTC596; tretinoin,PTC596 + tretinoin
C687,drug_combination,6,2,Anti-PD-1 Drugs; Cyclophosphamid,Anti-PD-1 Drugs + Cyclophosphamid
C686,drug_combination,6,2,Bevacizumab Avastin; Cyclophosphamid,Bevacizumab Avastin + Cyclophosphamid
C685,drug_combination,6,2,Mocetinostat Induction Phase + Ipilimumab + Nivolumab; tretinoin,Mocetinostat Induction Phase + Ipilimumab + Nivolumab + tretinoin
C684,drug_combination,6,2,chlorambucil drug; tretinoin,chlorambucil drug + tretinoin
C683,drug_combination,6,2,concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME; tretinoin,concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME + tretinoin
C682,drug_combination,6,2,Nivolumab -/kg; tretinoin,Nivolumab -/kg + tretinoin
C681,drug_combination,6,2,Cyclophosphamid; trametinib dimethyl sulfoxide,Cyclophosphamid + trametinib dimethyl sulfoxide
C679,drug_combination,6,2,tazemetostat hydrobromide; tretinoin,tazemetostat hydrobromide + tretinoin
C689,drug_combination,6,2,***; Cyclophosphamid,*** + Cyclophosphamid
C678,drug_combination,6,2,Cyclophosphamid; Serplulimab combined with bevacizumab and first-line chemotherapy,Cyclophosphamid + Serplulimab combined with bevacizumab and first-line chemotherapy
C677,drug_combination,6,2,Cyclophosphamide; DIFLUOROMETHYLORNITHINE,Cyclophosphamide + DIFLUOROMETHYLORNITHINE
C676,drug_combination,6,2,tazemetostat; tretinoin,tazemetostat + tretinoin
C675,drug_combination,6,2,Cyclophosphamid; LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide,Cyclophosphamid + LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide
C674,drug_combination,6,2,Adjuvant Atezolizumab-Bevacizumab Therapy; tretinoin,Adjuvant Atezolizumab-Bevacizumab Therapy + tretinoin
C673,drug_combination,6,2,Bevacizumab-IRDye800CW; tretinoin,Bevacizumab-IRDye800CW + tretinoin
C672,drug_combination,6,2,palbociclib isethionate; tretinoin,palbociclib isethionate + tretinoin
C688,drug_combination,6,2,Cyclophosphamid; Fenretinide,Cyclophosphamid + Fenretinide
C690,drug_combination,6,2,Cyclophosphamid; SAHA(Suberoylanilide,Cyclophosphamid + SAHA(Suberoylanilide
C670,drug_combination,6,2,Investigational Chemotherapy (unspecified); mesna,Investigational Chemotherapy (unspecified) + mesna
C701,drug_combination,6,2,Cyclophosphamide; Drugs Approved for Conditions Related to Cancer,Cyclophosphamide + Drugs Approved for Conditions Related to Cancer
C707,drug_combination,6,2,Cyclophosphamide; FOLFIRI-BEVACIZUMAB,Cyclophosphamide + FOLFIRI-BEVACIZUMAB
C631,drug_combination,6,2,Cyclophosphamid; tazemetostat hydrobromide,Cyclophosphamid + tazemetostat hydrobromide
C706,drug_combination,6,2,Cyclophosphamid; Nivolumab maintenance,Cyclophosphamid + Nivolumab maintenance
C705,drug_combination,6,2,Access to Experimental Drugs; tretinoin,Access to Experimental Drugs + tretinoin
C704,drug_combination,6,2,Cyclophosphamid; Trametinib placebo,Cyclophosphamid + Trametinib placebo
C703,drug_combination,6,2,"Bevacizumab, Everolimus and LBH589; Cyclophosphamid","Bevacizumab, Everolimus and LBH589 + Cyclophosphamid"
C702,drug_combination,6,2,Cyclophosphamide; once daily for two consecutive days Picato,Cyclophosphamide + once daily for two consecutive days Picato
C700,drug_combination,6,2,fenretinide lipid matrix; tretinoin,fenretinide lipid matrix + tretinoin
C691,drug_combination,6,2,pegfilgrastim; tretinoin,pegfilgrastim + tretinoin
C699,drug_combination,6,2,Cyclophosphamide; Relatlimab FDC + Nivolumab,Cyclophosphamide + Relatlimab FDC + Nivolumab
C698,drug_combination,6,2,Cyclophosphamide; Trifluridine/tipiracil + bevacizumab,Cyclophosphamide + Trifluridine/tipiracil + bevacizumab
C697,drug_combination,6,2,Drugs Approved for Different Types of Cancer; tretinoin,Drugs Approved for Different Types of Cancer + tretinoin
C696,drug_combination,6,2,Cyclophosphamid; two-drug chemotherapy group,Cyclophosphamid + two-drug chemotherapy group
C694,drug_combination,6,2,Everolimus Afinitor tablets; tretinoin,Everolimus Afinitor tablets + tretinoin
C693,drug_combination,6,2,CUDC-907; Cyclophosphamide,CUDC-907 + Cyclophosphamide
C692,drug_combination,6,2,tretinoin; vincristine,tretinoin + vincristine
C671,drug_combination,6,2,Cyclophosphamide; TAK-580,Cyclophosphamide + TAK-580
C695,drug_combination,6,2,ntifier:ADVL0921; tretinoin,ntifier:ADVL0921 + tretinoin
C669,drug_combination,6,2,Access to Experimental Drugs; Cyclophosphamid,Access to Experimental Drugs + Cyclophosphamid
C650,drug_combination,6,2,Cyclophosphamide; Placebo - Concentrate,Cyclophosphamide + Placebo - Concentrate
C648,drug_combination,6,2,Cyclophosphamid; Nivolumab with chemoradiation,Cyclophosphamid + Nivolumab with chemoradiation
C647,drug_combination,6,2,AZD1775; tretinoin,AZD1775 + tretinoin
C646,drug_combination,6,2,Drugs Approved for Conditions Related to Cancer; tretinoin,Drugs Approved for Conditions Related to Cancer + tretinoin
C645,drug_combination,6,2,"Cyclophosphamid; standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001","Cyclophosphamid + standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001"
C644,drug_combination,6,2,Cyclophosphamid; concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX,Cyclophosphamid + concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX
C643,drug_combination,6,2,Cyclophosphamide; mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody,Cyclophosphamide + mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody
C642,drug_combination,6,2,everolimus; tretinoin,everolimus + tretinoin
C641,drug_combination,6,2,AMG386 and bevacizumab; tretinoin,AMG386 and bevacizumab + tretinoin
C640,drug_combination,6,2,Surufatinib and Serplulimab; tretinoin,Surufatinib and Serplulimab + tretinoin
C638,drug_combination,6,2,AMG386 and bevacizumab; Cyclophosphamide,AMG386 and bevacizumab + Cyclophosphamide
C637,drug_combination,6,2,Cyclophosphamid; Surufatinib plus chemotherapy,Cyclophosphamid + Surufatinib plus chemotherapy
C636,drug_combination,6,2,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; tretinoin,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy + tretinoin
C635,drug_combination,6,2,Drugs Approved for Childhood Cancers; tretinoin,Drugs Approved for Childhood Cancers + tretinoin
C634,drug_combination,6,2,Nivolumab and Relatlimab-rmbw; tretinoin,Nivolumab and Relatlimab-rmbw + tretinoin
C668,drug_combination,6,2,Chemo with concomitant Capecitabine and KD018; tretinoin,Chemo with concomitant Capecitabine and KD018 + tretinoin
C633,drug_combination,6,2,Cyclophosphamid; vorinostat,Cyclophosphamid + vorinostat
C632,drug_combination,6,2,Cyclophosphamide; DS-8273a + nivolumab,Cyclophosphamide + DS-8273a + nivolumab
C649,drug_combination,6,2,tretinoin; vorinostat,tretinoin + vorinostat
C639,drug_combination,6,2,Cyclophosphamid; ONC201,Cyclophosphamid + ONC201
C651,drug_combination,6,2,trametinib dimethyl sulfoxide; tretinoin,trametinib dimethyl sulfoxide + tretinoin
C659,drug_combination,6,2,Trametinib placebo; tretinoin,Trametinib placebo + tretinoin
C665,drug_combination,6,2,"Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; Cyclophosphamide","Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab + Cyclophosphamide"
C666,drug_combination,6,2,Cyclophosphamid; everolimus,Cyclophosphamid + everolimus
C652,drug_combination,6,2,Cyclophosphamide; Drugs Approved for Childhood Cancers,Cyclophosphamide + Drugs Approved for Childhood Cancers
C667,drug_combination,6,2,TAK-580; tretinoin,TAK-580 + tretinoin
C664,drug_combination,6,2,Chemo with concomitant Capecitabine and KD018; Cyclophosphamide,Chemo with concomitant Capecitabine and KD018 + Cyclophosphamide
C663,drug_combination,6,2,AZD6244; Cyclophosphamid,AZD6244 + Cyclophosphamid
C661,drug_combination,6,2,Pemetrexed and Gemcitabine plus Bevacizumab; tretinoin,Pemetrexed and Gemcitabine plus Bevacizumab + tretinoin
C660,drug_combination,6,2,IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks; tretinoin,IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks + tretinoin
C662,drug_combination,6,2,LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide; tretinoin,LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide + tretinoin
C655,drug_combination,6,2,Cyclophosphamid; paclitaxel + everolimus RAD001,Cyclophosphamid + paclitaxel + everolimus RAD001
C657,drug_combination,6,2,intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks; tretinoin,intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks + tretinoin
C656,drug_combination,6,2,BRAF inhibitor dabrafenib and MEK inhibitor trametinib; Cyclophosphamide,BRAF inhibitor dabrafenib and MEK inhibitor trametinib + Cyclophosphamide
C653,drug_combination,6,2,Cyclophosphamide; Oncolytic virus VRT106,Cyclophosphamide + Oncolytic virus VRT106
C654,drug_combination,6,2,Cyclophosphamid; Oncaspar,Cyclophosphamid + Oncaspar
C658,drug_combination,6,2,ONC201; tretinoin,ONC201 + tretinoin
C1014,drug_combination,5,2,"Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab; Mekinist","Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab + Mekinist"
C1020,drug_combination,5,2,AZD1775; Mekinist,AZD1775 + Mekinist
C1019,drug_combination,5,2,Drugs Approved for Conditions Related to Cancer; Mekinist,Drugs Approved for Conditions Related to Cancer + Mekinist
C1018,drug_combination,5,2,Mekinist; fenretinide lipid matrix,Mekinist + fenretinide lipid matrix
C1016,drug_combination,5,2,Drugs Approved for Childhood Cancers; Mekinist,Drugs Approved for Childhood Cancers + Mekinist
C1017,drug_combination,5,2,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; Mekinist,Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy + Mekinist
C1012,drug_combination,5,2,MK-1775; Mekinist,MK-1775 + Mekinist
C1015,drug_combination,5,2,"Mekinist; rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim","Mekinist + rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim"
C1013,drug_combination,5,2,Mekinist; loncastuximab tesirine,Mekinist + loncastuximab tesirine
C1022,drug_combination,5,2,Mekinist; selinexor,Mekinist + selinexor
C1021,drug_combination,5,2,Mekinist; Mocetinostat Induction Phase + Ipilimumab + Nivolumab,Mekinist + Mocetinostat Induction Phase + Ipilimumab + Nivolumab
C1029,drug_combination,5,2,Mekinist; intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks,Mekinist + intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks
C1023,drug_combination,5,2,Mekinist; Nivolumab & Ipilimumab,Mekinist + Nivolumab & Ipilimumab
C1024,drug_combination,5,2,Mekinist; Pemetrexed and Gemcitabine plus Bevacizumab,Mekinist + Pemetrexed and Gemcitabine plus Bevacizumab
C1025,drug_combination,5,2,LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide; Mekinist,LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide + Mekinist
C1026,drug_combination,5,2,Mekinist; chlorambucil drug,Mekinist + chlorambucil drug
C1027,drug_combination,5,2,Mekinist; Palbociclib100mg,Mekinist + Palbociclib100mg
C1028,drug_combination,5,2,DIFLUOROMETHYLORNITHINE; Mekinist,DIFLUOROMETHYLORNITHINE + Mekinist
C1030,drug_combination,5,2,Mekinist; albumin-bound paclitaxe combined with bevacizumab biosimilar,Mekinist + albumin-bound paclitaxe combined with bevacizumab biosimilar
C1031,drug_combination,5,2,Bevacizumab-IRDye800CW; Mekinist,Bevacizumab-IRDye800CW + Mekinist
C1032,drug_combination,5,2,Adjuvant Atezolizumab-Bevacizumab Therapy; Mekinist,Adjuvant Atezolizumab-Bevacizumab Therapy + Mekinist
C1033,drug_combination,5,2,Mekinist; ONO-7475 once daily,Mekinist + ONO-7475 once daily
C1010,drug_combination,5,2,Mekinist; epirubicin - cyclophosphamide / docetaxel + bevacizumab,Mekinist + epirubicin - cyclophosphamide / docetaxel + bevacizumab
C1035,drug_combination,5,2,Mekinist; Trifluridine/tipiracil + bevacizumab,Mekinist + Trifluridine/tipiracil + bevacizumab
C1034,drug_combination,5,2,Mekinist; bevacizumab,Mekinist + bevacizumab
C1011,drug_combination,5,2,Mekinist; Nivolumab and Hyaluronidase-nvhy,Mekinist + Nivolumab and Hyaluronidase-nvhy
C992,drug_combination,5,2,Mekinist; Serplulimab combined with bevacizumab and first-line chemotherapy,Mekinist + Serplulimab combined with bevacizumab and first-line chemotherapy
C1009,drug_combination,5,2,131-MIBG + Vorinostat; Mekinist,131-MIBG + Vorinostat + Mekinist
C1008,drug_combination,5,2,Cemiplimab REGN2810; Mekinist,Cemiplimab REGN2810 + Mekinist
C983,drug_combination,5,2,Mekinist; Nivolumab with chemoradiation,Mekinist + Nivolumab with chemoradiation
C1037,drug_combination,5,2,Mekinist; Surufatinib and Serplulimab,Mekinist + Surufatinib and Serplulimab
C984,drug_combination,5,2,BRAF inhibitor dabrafenib and MEK inhibitor trametinib; Mekinist,BRAF inhibitor dabrafenib and MEK inhibitor trametinib + Mekinist
C985,drug_combination,5,2,Chemo with concomitant Capecitabine and KD018; Mekinist,Chemo with concomitant Capecitabine and KD018 + Mekinist
C986,drug_combination,5,2,"Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; Mekinist","Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab + Mekinist"
C987,drug_combination,5,2,"Enzalutamide,, soft capsules, once daily; Mekinist","Enzalutamide,, soft capsules, once daily + Mekinist"
C988,drug_combination,5,2,Mekinist; Oncaspar,Mekinist + Oncaspar
C989,drug_combination,5,2,Mekinist; paclitaxel + everolimus RAD001,Mekinist + paclitaxel + everolimus RAD001
C990,drug_combination,5,2,Anti-PD-1 Drugs; Mekinist,Anti-PD-1 Drugs + Mekinist
C991,drug_combination,5,2,Mekinist; everolimus,Mekinist + everolimus
C993,drug_combination,5,2,Mekinist; trametinib dimethyl sulfoxide,Mekinist + trametinib dimethyl sulfoxide
C994,drug_combination,5,2,CUDC-907; Mekinist,CUDC-907 + Mekinist
C995,drug_combination,5,2,Everolimus Afinitor tablets; Mekinist,Everolimus Afinitor tablets + Mekinist
C996,drug_combination,5,2,Mekinist; SAHA(Suberoylanilide,Mekinist + SAHA(Suberoylanilide
C997,drug_combination,5,2,FOLFIRI-BEVACIZUMAB; Mekinist,FOLFIRI-BEVACIZUMAB + Mekinist
C998,drug_combination,5,2,DFMO; Mekinist,DFMO + Mekinist
C999,drug_combination,5,2,Mekinist; two-drug chemotherapy group,Mekinist + two-drug chemotherapy group
C1000,drug_combination,5,2,ETBX-071 PSA-based Oncolytic Virus; Mekinist,ETBX-071 PSA-based Oncolytic Virus + Mekinist
C1001,drug_combination,5,2,Antibody-Drug Conjugates; Mekinist,Antibody-Drug Conjugates + Mekinist
C1002,drug_combination,5,2,"Combination, Rogaratinib + palbociclib + fulvestrant; Mekinist","Combination, Rogaratinib + palbociclib + fulvestrant + Mekinist"
C1003,drug_combination,5,2,Mekinist; Trametinib placebo,Mekinist + Trametinib placebo
C1004,drug_combination,5,2,Mekinist; Nivolumab maintenance,Mekinist + Nivolumab maintenance
C1005,drug_combination,5,2,Mekinist; ntifier:ADVL0921,Mekinist + ntifier:ADVL0921
C1006,drug_combination,5,2,Mekinist; loncastuximab tesirine-lpyl,Mekinist + loncastuximab tesirine-lpyl
C1007,drug_combination,5,2,Mekinist; palbociclib isethionate,Mekinist + palbociclib isethionate
C1036,drug_combination,5,2,Mekinist; Nivolumab-relatlimab FDC,Mekinist + Nivolumab-relatlimab FDC
C1075,drug_combination,5,2,Mekinist; Surufatinib,Mekinist + Surufatinib
C1038,drug_combination,5,2,Mekinist; palbociclib,Mekinist + palbociclib
C1080,drug_combination,5,2,Mekinist; nivolumab,Mekinist + nivolumab
C1068,drug_combination,5,2,Dabrafenib and trametinib combination; Mekinist,Dabrafenib and trametinib combination + Mekinist
C1069,drug_combination,5,2,Mekinist; Oncolytic virus VRT106,Mekinist + Oncolytic virus VRT106
C1070,drug_combination,5,2,Fenretinide; Mekinist,Fenretinide + Mekinist
C1071,drug_combination,5,2,Mekinist; Three-drug chemotherapy group,Mekinist + Three-drug chemotherapy group
C1072,drug_combination,5,2,Mekinist; TAK-580,Mekinist + TAK-580
C1073,drug_combination,5,2,Mekinist; dasatinib,Mekinist + dasatinib
C1074,drug_combination,5,2,1A46 Drug Substance; Mekinist,1A46 Drug Substance + Mekinist
C1076,drug_combination,5,2,Combination drug; Mekinist,Combination drug + Mekinist
C1077,drug_combination,5,2,Bortezomib drug; Mekinist,Bortezomib drug + Mekinist
C1078,drug_combination,5,2,Mekinist; Nivolumab induction,Mekinist + Nivolumab induction
C1079,drug_combination,5,2,Mekinist; Nivolumab -/kg,Mekinist + Nivolumab -/kg
C1081,drug_combination,5,2,Mekinist; Relatlimab FDC + Nivolumab,Mekinist + Relatlimab FDC + Nivolumab
C1066,drug_combination,5,2,"Bevacizumab, Everolimus and LBH589; Mekinist","Bevacizumab, Everolimus and LBH589 + Mekinist"
C1082,drug_combination,5,2,Mekinist; once daily for two consecutive days Picato,Mekinist + once daily for two consecutive days Picato
C1083,drug_combination,5,2,AMG386 and bevacizumab; Mekinist,AMG386 and bevacizumab + Mekinist
C1084,drug_combination,5,2,Ziextenzo; methotrexate,Ziextenzo + methotrexate
C1085,drug_combination,5,2,Leucovorin; Ziextenzo,Leucovorin + Ziextenzo
C1086,drug_combination,5,2,cabozantinib; cabozantinib s-malate,cabozantinib + cabozantinib s-malate
C1087,drug_combination,5,2,tazemetostat; topotecan,tazemetostat + topotecan
C1088,drug_combination,5,2,dinutuximab; isotretinoin,dinutuximab + isotretinoin
C1089,drug_combination,5,2,dinutuximab; tretinoin,dinutuximab + tretinoin
C1090,drug_combination,5,2,carboplatin; vinblastine,carboplatin + vinblastine
C1091,drug_combination,5,2,Vinblastin; carboplatin,Vinblastin + carboplatin
C981,drug_combination,5,2,"Mekinist; standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001","Mekinist + standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001"
C1067,drug_combination,5,2,Mekinist; Placebo - Concentrate,Mekinist + Placebo - Concentrate
C1065,drug_combination,5,2,Mekinist; ipilimumab,Mekinist + ipilimumab
C1039,drug_combination,5,2,"Mekinist; PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001","Mekinist + PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001"
C1051,drug_combination,5,2,Mekinist; carboplatin paclitaxel bevacizumab,Mekinist + carboplatin paclitaxel bevacizumab
C1040,drug_combination,5,2,Mekinist; Palbociclib125mg,Mekinist + Palbociclib125mg
C1041,drug_combination,5,2,Mekinist; PTC596,Mekinist + PTC596
C1042,drug_combination,5,2,Drugs Approved for Different Types of Cancer; Mekinist,Drugs Approved for Different Types of Cancer + Mekinist
C1043,drug_combination,5,2,Mekinist; tazemetostat,Mekinist + tazemetostat
C1044,drug_combination,5,2,Mekinist; concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME,Mekinist + concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME
C1045,drug_combination,5,2,Mekinist; Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab,Mekinist + Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab
C1046,drug_combination,5,2,AZD6244; Mekinist,AZD6244 + Mekinist
C1047,drug_combination,5,2,Mekinist; SAHA-Suberoylanilide,Mekinist + SAHA-Suberoylanilide
C1048,drug_combination,5,2,Access to Experimental Drugs; Mekinist,Access to Experimental Drugs + Mekinist
C1049,drug_combination,5,2,Mekinist; Recombinant oncolytic herpes simplex virus type Ⅰ R130,Mekinist + Recombinant oncolytic herpes simplex virus type Ⅰ R130
C1050,drug_combination,5,2,Indoximod; Mekinist,Indoximod + Mekinist
C1052,drug_combination,5,2,Mekinist; Nivolumab Protocol,Mekinist + Nivolumab Protocol
C1064,drug_combination,5,2,Mekinist; mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody,Mekinist + mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody
C1053,drug_combination,5,2,Drug-based intervention; Mekinist,Drug-based intervention + Mekinist
C1054,drug_combination,5,2,Bevacizumab Avastin; Mekinist,Bevacizumab Avastin + Mekinist
C1055,drug_combination,5,2,Mekinist; SAHA/Vorinostat,Mekinist + SAHA/Vorinostat
C1056,drug_combination,5,2,DS-8273a + nivolumab; Mekinist,DS-8273a + nivolumab + Mekinist
C1057,drug_combination,5,2,"Mekinist; capecitabine, oxaliplatin, irinotecan and bevacizumab","Mekinist + capecitabine, oxaliplatin, irinotecan and bevacizumab"
C1058,drug_combination,5,2,Mekinist; Nivolumab and Relatlimab-rmbw,Mekinist + Nivolumab and Relatlimab-rmbw
C1059,drug_combination,5,2,***; Mekinist,*** + Mekinist
C1060,drug_combination,5,2,LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide; Mekinist,LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide + Mekinist
C1061,drug_combination,5,2,Mekinist; Trastuzumab+Nivolumab+Gemcitabine+Cisplatin,Mekinist + Trastuzumab+Nivolumab+Gemcitabine+Cisplatin
C1062,drug_combination,5,2,Fimepinostat; Mekinist,Fimepinostat + Mekinist
C1063,drug_combination,5,2,Ipilimumab -/kg; Mekinist,Ipilimumab -/kg + Mekinist
C982,drug_combination,5,2,IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks; Mekinist,IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks + Mekinist
C1092,drug_combination,5,2,cytarabine; topotecan,cytarabine + topotecan
C980,drug_combination,5,2,Mekinist; concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX,Mekinist + concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX
C935,drug_combination,5,2,mesna; tretinoin,mesna + tretinoin
C929,drug_combination,5,2,cytarabine; thiotepa,cytarabine + thiotepa
C930,drug_combination,5,2,Cyclophosphamid; busulfan,Cyclophosphamid + busulfan
C931,drug_combination,5,2,Cyclophosphamid; defibrotide,Cyclophosphamid + defibrotide
C932,drug_combination,5,2,busulfan; mesna,busulfan + mesna
C933,drug_combination,5,2,Cyclophosphamide; busulfan,Cyclophosphamide + busulfan
C934,drug_combination,5,2,cisplatin; tretinoin,cisplatin + tretinoin
C936,drug_combination,5,2,isotretinoin; pegfilgrastim,isotretinoin + pegfilgrastim
C927,drug_combination,5,2,pegfilgrastim; sirolimus,pegfilgrastim + sirolimus
C937,drug_combination,5,2,isotretinoin; vincristine,isotretinoin + vincristine
C938,drug_combination,5,2,etoposide; tazemetostat,etoposide + tazemetostat
C939,drug_combination,5,2,etoposide; nivolumab,etoposide + nivolumab
C940,drug_combination,5,2,etoposide; vorinostat,etoposide + vorinostat
C941,drug_combination,5,2,Ziextenzo; dexrazoxane,Ziextenzo + dexrazoxane
C942,drug_combination,5,2,Ziextenzo; doxorubicin,Ziextenzo + doxorubicin
C928,drug_combination,5,2,Cyclophosphamide; defibrotide,Cyclophosphamide + defibrotide
C926,drug_combination,5,2,filgrastim; sirolimus,filgrastim + sirolimus
C944,drug_combination,5,2,Progesterone; dexrazoxane,Progesterone + dexrazoxane
P011,complete_drug_set,5,4,Temozolomide capsule; bevacizumab; irinotecan; temozolomide,"4 drugs: Temozolomide capsule, bevacizumab, irinotecan, temozolomide"
P005,complete_drug_set,5,2,Progesterone; Valproic Acid,"2 drugs: Progesterone, Valproic Acid"
P006,complete_drug_set,5,2,Ketoconazole; triamcinolone,"2 drugs: Ketoconazole, triamcinolone"
P007,complete_drug_set,5,10,Cyclophosphamid; Cyclophosphamide; dexrazoxane; doxorubicin; etoposide; filgrastim; ifosfamide; mesna; pegfilgrastim; vincristine,"10 drugs: Cyclophosphamid, Cyclophosphamide, dexrazoxane, doxorubicin, etoposide"
P008,complete_drug_set,5,5,Dabrafenib Mesylate; Mekinist; Tafinlar; dabrafenib; trametinib,"5 drugs: Dabrafenib Mesylate, Mekinist, Tafinlar, dabrafenib, trametinib"
P009,complete_drug_set,5,6,carboplatin; etoposide; filgrastim; ifosfamide; mesna; pegfilgrastim,"6 drugs: carboplatin, etoposide, filgrastim, ifosfamide, mesna"
P010,complete_drug_set,5,2,carboplatin; etoposide,"2 drugs: carboplatin, etoposide"
C918,drug_combination,5,2,Ketoconazole; Progesterone,Ketoconazole + Progesterone
C925,drug_combination,5,2,Valproic Acid; topotecan,Valproic Acid + topotecan
C919,drug_combination,5,2,Progesterone; ipilimumab,Progesterone + ipilimumab
C920,drug_combination,5,2,Cyclophosphamide; Emend,Cyclophosphamide + Emend
C921,drug_combination,5,2,Emend; vincristine,Emend + vincristine
C922,drug_combination,5,2,Cyclophosphamid; Emend,Cyclophosphamid + Emend
C923,drug_combination,5,2,Emend; temozolomide,Emend + temozolomide
C979,drug_combination,5,2,Mekinist; ONC201,Mekinist + ONC201
C943,drug_combination,5,2,Neulasta; cytarabine,Neulasta + cytarabine
C924,drug_combination,5,2,ATRA; Valproic Acid,ATRA + Valproic Acid
C945,drug_combination,5,2,Progesterone; methotrexate,Progesterone + methotrexate
C978,drug_combination,5,2,Mekinist; Surufatinib plus chemotherapy,Mekinist + Surufatinib plus chemotherapy
C965,drug_combination,5,2,Glutamine; temozolomide,Glutamine + temozolomide
C966,drug_combination,5,2,etoposide phosphate; melphalan,etoposide phosphate + melphalan
C967,drug_combination,5,2,GM-CSF; dasatinib,GM-CSF + dasatinib
C968,drug_combination,5,2,Etopophos; melphalan,Etopophos + melphalan
C969,drug_combination,5,2,osimertinib; osimertinib mesylate,osimertinib + osimertinib mesylate
C971,drug_combination,5,2,lomustine; pegfilgrastim,lomustine + pegfilgrastim
C977,drug_combination,5,2,Mekinist; vorinostat,Mekinist + vorinostat
C963,drug_combination,5,2,sirolimus; vorinostat,sirolimus + vorinostat
C976,drug_combination,5,2,Mekinist; tazemetostat hydrobromide,Mekinist + tazemetostat hydrobromide
C975,drug_combination,5,2,Neupogen; mesna,Neupogen + mesna
C974,drug_combination,5,2,G-CSF; Neupogen,G-CSF + Neupogen
C973,drug_combination,5,2,Ketoconazole; Mekinist,Ketoconazole + Mekinist
C972,drug_combination,5,2,ATRA; trametinib,ATRA + trametinib
C946,drug_combination,5,2,Ziextenzo; ifosfamide,Ziextenzo + ifosfamide
C964,drug_combination,5,2,temozolomide; thiotepa,temozolomide + thiotepa
C970,drug_combination,5,2,filgrastim; lomustine,filgrastim + lomustine
C962,drug_combination,5,2,Investigational Chemotherapy (unspecified); irinotecan,Investigational Chemotherapy (unspecified) + irinotecan
C954,drug_combination,5,2,cytarabine; gemtuzumab ozogamicin,cytarabine + gemtuzumab ozogamicin
C948,drug_combination,5,2,GM-CSF; dexrazoxane,GM-CSF + dexrazoxane
C949,drug_combination,5,2,pegaspargase; vincristine,pegaspargase + vincristine
C950,drug_combination,5,2,methotrexate; pegaspargase,methotrexate + pegaspargase
C951,drug_combination,5,2,IMPACT; pegfilgrastim,IMPACT + pegfilgrastim
C952,drug_combination,5,2,cytarabine; mercaptopurine,cytarabine + mercaptopurine
C953,drug_combination,5,2,IMPACT; filgrastim,IMPACT + filgrastim
C955,drug_combination,5,2,Zarxio; mesna,Zarxio + mesna
C947,drug_combination,5,2,irinotecan; topotecan,irinotecan + topotecan
C956,drug_combination,5,2,Zarxio; plerixafor,Zarxio + plerixafor
C957,drug_combination,5,2,Zarxio; vincristine,Zarxio + vincristine
C958,drug_combination,5,2,Zarxio; cisplatin,Zarxio + cisplatin
C959,drug_combination,5,2,thiotepa; topotecan,thiotepa + topotecan
C960,drug_combination,5,2,dasatinib; irinotecan,dasatinib + irinotecan
C961,drug_combination,5,2,GM-CSF; doxorubicin,GM-CSF + doxorubicin
P014,complete_drug_set,4,3,bevacizumab; carboplatin; vincristine,"3 drugs: bevacizumab, carboplatin, vincristine"
P012,complete_drug_set,4,2,Lupron Depot; leuprolide,"2 drugs: Lupron Depot, leuprolide"
P013,complete_drug_set,4,5,Cyclophosphamid; Cyclophosphamide; cisplatin; lomustine; vincristine,"5 drugs: Cyclophosphamid, Cyclophosphamide, cisplatin, lomustine, vincristine"
P015,complete_drug_set,3,6,Temozolomide capsule; Valproic Acid; bevacizumab; etoposide; irinotecan; temozolomide,"6 drugs: Temozolomide capsule, Valproic Acid, bevacizumab, etoposide, irinotecan"
P016,complete_drug_set,3,14,Cyclophosphamid; Cyclophosphamide; Temozolomide capsule; cisplatin; cytarabine; dactinomycin; dexrazoxane; doxorubicin; etoposide; filgrastim; methotrexate; pegfilgrastim; temozolomide; vincristine,"14 drugs: Cyclophosphamid, Cyclophosphamide, Temozolomide capsule, cisplatin, cytarabine"
P017,complete_drug_set,3,15,Cyclophosphamid; Cyclophosphamide; G-CSF; GM-CSF; Glutamine; Leucovorin; carboplatin; cisplatin; etoposide; filgrastim; mesna; methotrexate; pegfilgrastim; thiotepa; vincristine,"15 drugs: Cyclophosphamid, Cyclophosphamide, G-CSF, GM-CSF, Glutamine"
P018,complete_drug_set,3,3,Temozolomide capsule; lomustine; temozolomide,"3 drugs: Temozolomide capsule, lomustine, temozolomide"
P019,complete_drug_set,3,2,Testosterone Cypionate; triamcinolone,"2 drugs: Testosterone Cypionate, triamcinolone"
P020,complete_drug_set,3,3,Temozolomide capsule; bevacizumab; temozolomide,"3 drugs: Temozolomide capsule, bevacizumab, temozolomide"
P021,complete_drug_set,3,111,"***; 131-MIBG + Vorinostat; 1A46 Drug Substance; AMG386 and bevacizumab; AZD1775; AZD6244; Access to Experimental Drugs; Adjuvant Atezolizumab-Bevacizumab Therapy; Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; Anti-PD-1 Drugs; Antibody-Drug Conjugates; BRAF inhibitor dabrafenib and MEK inhibitor trametinib; Bevacizumab Avastin; Bevacizumab, Everolimus and LBH589; Bevacizumab-IRDye800CW; Bortezomib drug; CUDC-907; Cemiplimab REGN2810; Chemo with concomitant Capecitabine and KD018; Combination drug; Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; Combination, Rogaratinib + palbociclib + fulvestrant; DFMO; DIFLUOROMETHYLORNITHINE; DS-8273a + nivolumab; Dabrafenib and trametinib combination; Drug-based intervention; Drugs Approved for Childhood Cancers; Drugs Approved for Conditions Related to Cancer; Drugs Approved for Different Types of Cancer; ETBX-071 PSA-based Oncolytic Virus; Enzalutamide,, soft capsules, once daily; Everolimus Afinitor tablets; FOLFIRI-BEVACIZUMAB; Fenretinide; Fimepinostat; IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks; Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab; Indoximod; Investigational Chemotherapy (unspecified); Ipilimumab -/kg; LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide; LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide; MK-1775; Mocetinostat Induction Phase + Ipilimumab + Nivolumab; Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab; Nivolumab & Ipilimumab; Nivolumab -/kg; Nivolumab Protocol; Nivolumab and Hyaluronidase-nvhy; Nivolumab and Relatlimab-rmbw; Nivolumab induction; Nivolumab maintenance; Nivolumab with chemoradiation; Nivolumab-relatlimab FDC; ONC201; ONO-7475 once daily; Oncaspar; Oncolytic virus VRT106; PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001; PTC596; Palbociclib100mg; Palbociclib125mg; Pemetrexed and Gemcitabine plus Bevacizumab; Placebo - Concentrate; Recombinant oncolytic herpes simplex virus type Ⅰ R130; Relatlimab FDC + Nivolumab; SAHA(Suberoylanilide; SAHA-Suberoylanilide; SAHA/Vorinostat; Serplulimab combined with bevacizumab and first-line chemotherapy; Surufatinib; Surufatinib and Serplulimab; Surufatinib plus chemotherapy; TAK-580; Three-drug chemotherapy group; Trametinib placebo; Trastuzumab+Nivolumab+Gemcitabine+Cisplatin; Trifluridine/tipiracil + bevacizumab; albumin-bound paclitaxe combined with bevacizumab biosimilar; bevacizumab; capecitabine, oxaliplatin, irinotecan and bevacizumab; carboplatin paclitaxel bevacizumab; chlorambucil drug; concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME; concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX; dasatinib; epirubicin - cyclophosphamide / docetaxel + bevacizumab; everolimus; fenretinide lipid matrix; intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks; ipilimumab; loncastuximab tesirine; loncastuximab tesirine-lpyl; mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody; nivolumab; ntifier:ADVL0921; once daily for two consecutive days Picato; paclitaxel + everolimus RAD001; palbociclib; palbociclib isethionate; rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim; selinexor; standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001; tazemetostat; tazemetostat hydrobromide; trametinib; trametinib dimethyl sulfoxide; triamcinolone; two-drug chemotherapy group; vorinostat","111 drugs: ***, 131-MIBG + Vorinostat, 1A46 Drug Substance, AMG386 and bevacizumab, AZD1775"
P022,complete_drug_set,3,3,cisplatin; lomustine; vincristine,"3 drugs: cisplatin, lomustine, vincristine"
P023,complete_drug_set,3,2,tretinoin; triamcinolone,"2 drugs: tretinoin, triamcinolone"
P024,complete_drug_set,3,7,Neulasta; carboplatin; etoposide; filgrastim; ifosfamide; mesna; pegfilgrastim,"7 drugs: Neulasta, carboplatin, etoposide, filgrastim, ifosfamide"
P025,complete_drug_set,3,2,Ketoconazole; Valproic Acid,"2 drugs: Ketoconazole, Valproic Acid"
P028,complete_drug_set,2,3,ATRA; carboplatin; vincristine,"3 drugs: ATRA, carboplatin, vincristine"
P026,complete_drug_set,2,3,Progesterone; carboplatin; vincristine,"3 drugs: Progesterone, carboplatin, vincristine"
P027,complete_drug_set,2,3,Ketoconazole; carboplatin; vincristine,"3 drugs: Ketoconazole, carboplatin, vincristine"
P042,complete_drug_set,2,3,Vitrakvi; larotrectinib; triamcinolone,"3 drugs: Vitrakvi, larotrectinib, triamcinolone"
P029,complete_drug_set,2,2,Testosterone Cypionate; lanreotide acetate,"2 drugs: Testosterone Cypionate, lanreotide acetate"
P030,complete_drug_set,2,4,carboplatin; etoposide; filgrastim; pegfilgrastim,"4 drugs: carboplatin, etoposide, filgrastim, pegfilgrastim"
P053,complete_drug_set,2,14,Cyclophosphamid; Cyclophosphamide; G-CSF; GM-CSF; Glutamine; carboplatin; cisplatin; etoposide; filgrastim; mesna; pegfilgrastim; thiotepa; triamcinolone; vincristine,"14 drugs: Cyclophosphamid, Cyclophosphamide, G-CSF, GM-CSF, Glutamine"
P052,complete_drug_set,2,8,Cyclophosphamid; Cyclophosphamide; Ziextenzo; cisplatin; filgrastim; mesna; pegfilgrastim; vincristine,"8 drugs: Cyclophosphamid, Cyclophosphamide, Ziextenzo, cisplatin, filgrastim"
P051,complete_drug_set,2,4,Temozolomide capsule; bevacizumab; nivolumab; temozolomide,"4 drugs: Temozolomide capsule, bevacizumab, nivolumab, temozolomide"
P050,complete_drug_set,2,8,Cyclophosphamid; Cyclophosphamide; etoposide; filgrastim; ifosfamide; mesna; pegfilgrastim; vincristine,"8 drugs: Cyclophosphamid, Cyclophosphamide, etoposide, filgrastim, ifosfamide"
P049,complete_drug_set,2,5,etoposide; filgrastim; ifosfamide; mesna; pegfilgrastim,"5 drugs: etoposide, filgrastim, ifosfamide, mesna, pegfilgrastim"
P048,complete_drug_set,2,113,"***; 131-MIBG + Vorinostat; 1A46 Drug Substance; AMG386 and bevacizumab; AZD1775; AZD6244; Access to Experimental Drugs; Adjuvant Atezolizumab-Bevacizumab Therapy; Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; Anti-PD-1 Drugs; Antibody-Drug Conjugates; BRAF inhibitor dabrafenib and MEK inhibitor trametinib; Bevacizumab Avastin; Bevacizumab, Everolimus and LBH589; Bevacizumab-IRDye800CW; Bortezomib drug; CUDC-907; Cemiplimab REGN2810; Chemo with concomitant Capecitabine and KD018; Combination drug; Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; Combination, Rogaratinib + palbociclib + fulvestrant; DFMO; DIFLUOROMETHYLORNITHINE; DS-8273a + nivolumab; Dabrafenib and trametinib combination; Drug-based intervention; Drugs Approved for Childhood Cancers; Drugs Approved for Conditions Related to Cancer; Drugs Approved for Different Types of Cancer; ETBX-071 PSA-based Oncolytic Virus; Enzalutamide,, soft capsules, once daily; Everolimus Afinitor tablets; FOLFIRI-BEVACIZUMAB; Fenretinide; Fimepinostat; IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks; Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab; Indoximod; Investigational Chemotherapy (unspecified); Ipilimumab -/kg; Ketoconazole; Koselugo; LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide; LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide; MK-1775; Mocetinostat Induction Phase + Ipilimumab + Nivolumab; Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab; Nivolumab & Ipilimumab; Nivolumab -/kg; Nivolumab Protocol; Nivolumab and Hyaluronidase-nvhy; Nivolumab and Relatlimab-rmbw; Nivolumab induction; Nivolumab maintenance; Nivolumab with chemoradiation; Nivolumab-relatlimab FDC; ONC201; ONO-7475 once daily; Oncaspar; Oncolytic virus VRT106; PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001; PTC596; Palbociclib100mg; Palbociclib125mg; Pemetrexed and Gemcitabine plus Bevacizumab; Placebo - Concentrate; Recombinant oncolytic herpes simplex virus type Ⅰ R130; Relatlimab FDC + Nivolumab; SAHA(Suberoylanilide; SAHA-Suberoylanilide; SAHA/Vorinostat; Serplulimab combined with bevacizumab and first-line chemotherapy; Surufatinib; Surufatinib and Serplulimab; Surufatinib plus chemotherapy; TAK-580; Three-drug chemotherapy group; Trametinib placebo; Trastuzumab+Nivolumab+Gemcitabine+Cisplatin; Trifluridine/tipiracil + bevacizumab; albumin-bound paclitaxe combined with bevacizumab biosimilar; bevacizumab; capecitabine, oxaliplatin, irinotecan and bevacizumab; carboplatin paclitaxel bevacizumab; chlorambucil drug; concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME; concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX; dasatinib; epirubicin - cyclophosphamide / docetaxel + bevacizumab; everolimus; fenretinide lipid matrix; intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks; ipilimumab; loncastuximab tesirine; loncastuximab tesirine-lpyl; mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody; nivolumab; ntifier:ADVL0921; once daily for two consecutive days Picato; paclitaxel + everolimus RAD001; palbociclib; palbociclib isethionate; rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim; selinexor; selumetinib; standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001; tazemetostat; tazemetostat hydrobromide; trametinib; trametinib dimethyl sulfoxide; two-drug chemotherapy group; vorinostat","113 drugs: ***, 131-MIBG + Vorinostat, 1A46 Drug Substance, AMG386 and bevacizumab, AZD1775"
P047,complete_drug_set,2,7,Cyclophosphamid; Cyclophosphamide; dactinomycin; filgrastim; mesna; pegfilgrastim; vincristine,"7 drugs: Cyclophosphamid, Cyclophosphamide, dactinomycin, filgrastim, mesna"
P046,complete_drug_set,2,4,lomustine; procarbazine; thioguanine; vincristine,"4 drugs: lomustine, procarbazine, thioguanine, vincristine"
P045,complete_drug_set,2,112,"***; 131-MIBG + Vorinostat; 1A46 Drug Substance; AMG386 and bevacizumab; AZD1775; AZD6244; Access to Experimental Drugs; Adjuvant Atezolizumab-Bevacizumab Therapy; Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy; Anti-PD-1 Drugs; Antibody-Drug Conjugates; BRAF inhibitor dabrafenib and MEK inhibitor trametinib; Bevacizumab Avastin; Bevacizumab, Everolimus and LBH589; Bevacizumab-IRDye800CW; Bortezomib drug; CUDC-907; Cemiplimab REGN2810; Chemo with concomitant Capecitabine and KD018; Combination drug; Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab; Combination, Rogaratinib + palbociclib + fulvestrant; DFMO; DIFLUOROMETHYLORNITHINE; DS-8273a + nivolumab; Dabrafenib and trametinib combination; Drug-based intervention; Drugs Approved for Childhood Cancers; Drugs Approved for Conditions Related to Cancer; Drugs Approved for Different Types of Cancer; ETBX-071 PSA-based Oncolytic Virus; Enzalutamide,, soft capsules, once daily; Everolimus Afinitor tablets; FOLFIRI-BEVACIZUMAB; Fenretinide; Fimepinostat; IV FOLFIRI+ target agent bevacizumab or cetuximab every 2 weeks; Imatinib, Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab; Indoximod; Investigational Chemotherapy (unspecified); Ipilimumab -/kg; LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide; LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide; MK-1775; Mocetinostat Induction Phase + Ipilimumab + Nivolumab; Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab; Nivolumab & Ipilimumab; Nivolumab -/kg; Nivolumab Protocol; Nivolumab and Hyaluronidase-nvhy; Nivolumab and Relatlimab-rmbw; Nivolumab induction; Nivolumab maintenance; Nivolumab with chemoradiation; Nivolumab-relatlimab FDC; ONC201; ONO-7475 once daily; Oncaspar; Oncolytic virus VRT106; PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001; PTC596; Palbociclib100mg; Palbociclib125mg; Pemetrexed and Gemcitabine plus Bevacizumab; Placebo - Concentrate; Recombinant oncolytic herpes simplex virus type Ⅰ R130; Relatlimab FDC + Nivolumab; SAHA(Suberoylanilide; SAHA-Suberoylanilide; SAHA/Vorinostat; Serplulimab combined with bevacizumab and first-line chemotherapy; Surufatinib; Surufatinib and Serplulimab; Surufatinib plus chemotherapy; TAK-580; Temozolomide capsule; Three-drug chemotherapy group; Trametinib placebo; Trastuzumab+Nivolumab+Gemcitabine+Cisplatin; Trifluridine/tipiracil + bevacizumab; albumin-bound paclitaxe combined with bevacizumab biosimilar; bevacizumab; capecitabine, oxaliplatin, irinotecan and bevacizumab; carboplatin paclitaxel bevacizumab; chlorambucil drug; concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME; concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX; dasatinib; epirubicin - cyclophosphamide / docetaxel + bevacizumab; everolimus; fenretinide lipid matrix; intra-arterial oxaliplatin + Systemic FOLFIRI + target agent bevacizumab or cetuximab every 2 weeks; ipilimumab; loncastuximab tesirine; loncastuximab tesirine-lpyl; mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody; nivolumab; ntifier:ADVL0921; once daily for two consecutive days Picato; paclitaxel + everolimus RAD001; palbociclib; palbociclib isethionate; rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim; selinexor; standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001; tazemetostat; tazemetostat hydrobromide; temozolomide; trametinib; trametinib dimethyl sulfoxide; two-drug chemotherapy group; vorinostat","112 drugs: ***, 131-MIBG + Vorinostat, 1A46 Drug Substance, AMG386 and bevacizumab, AZD1775"
P044,complete_drug_set,2,13,Cyclophosphamid; Cyclophosphamide; G-CSF; GM-CSF; Glutamine; carboplatin; cisplatin; etoposide; filgrastim; mesna; pegfilgrastim; thiotepa; vincristine,"13 drugs: Cyclophosphamid, Cyclophosphamide, G-CSF, GM-CSF, Glutamine"
P043,complete_drug_set,2,3,Temozolomide capsule; Valproic Acid; temozolomide,"3 drugs: Temozolomide capsule, Valproic Acid, temozolomide"
P041,complete_drug_set,2,2,isotretinoin; tretinoin,"2 drugs: isotretinoin, tretinoin"
P040,complete_drug_set,2,2,imiquimod; triamcinolone,"2 drugs: imiquimod, triamcinolone"
P039,complete_drug_set,2,7,dexrazoxane; doxorubicin; etoposide; filgrastim; ifosfamide; mesna; pegfilgrastim,"7 drugs: dexrazoxane, doxorubicin, etoposide, filgrastim, ifosfamide"
P037,complete_drug_set,2,2,Valproic Acid; triamcinolone,"2 drugs: Valproic Acid, triamcinolone"
P036,complete_drug_set,2,2,Progesterone; cabergoline,"2 drugs: Progesterone, cabergoline"
P035,complete_drug_set,2,3,Temozolomide capsule; irinotecan; temozolomide,"3 drugs: Temozolomide capsule, irinotecan, temozolomide"
P034,complete_drug_set,2,12,Cyclophosphamid; Cyclophosphamide; cisplatin; cytarabine; dexrazoxane; doxorubicin; etoposide; filgrastim; methotrexate; pegfilgrastim; temozolomide; vincristine,"12 drugs: Cyclophosphamid, Cyclophosphamide, cisplatin, cytarabine, dexrazoxane"
P033,complete_drug_set,2,2,ATRA; triamcinolone,"2 drugs: ATRA, triamcinolone"
P032,complete_drug_set,2,2,Ketoconazole; tretinoin,"2 drugs: Ketoconazole, tretinoin"
P031,complete_drug_set,2,7,Cyclophosphamid; Cyclophosphamide; carboplatin; etoposide; filgrastim; pegfilgrastim; vincristine,"7 drugs: Cyclophosphamid, Cyclophosphamide, carboplatin, etoposide, filgrastim"
P038,complete_drug_set,2,12,Cyclophosphamid; Cyclophosphamide; G-CSF; GM-CSF; Valproic Acid; cisplatin; etoposide; filgrastim; mesna; pegfilgrastim; temozolomide; vincristine,"12 drugs: Cyclophosphamid, Cyclophosphamide, G-CSF, GM-CSF, Valproic Acid"
